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ABSTRACT 
 
Sudden cardiac arrest is a leading cause of death in the United States. The neurophysiological  
mechanism underlying sudden cardiac arrest is not well understood. Recent studies from our 
laboratory demonstrate that asphyxia-induced sudden cardiac arrest leads to a surge of brain-
heart coupling, a novel form of neurophysiological activity measured by corticocardiac 
coherence (CCCoh) and directional connectivity (CCCon), prior to sudden death. In addition, 
surgical blockade of efferent signaling from the brain to the heart significantly delayed the death 
of both the heart and the brain during asphyxic cardiac arrest. We hypothesized that the 
stimulated brain functions to resuscitate the heart via activation of the sympathetic nervous 
system and that the surge of brain-heart coupling may be a potential biomarker for sudden 
cardiac arrest. In current thesis project, we tested our hypothesis in 3 different cardiac arrest 
models. 
In the first study, we tested the effectiveness of adrenergic blockers, phentolamine and 
atenolol, individually or combined, in prolonging functionality of the vital organs in asphyxic 
cardiac arrest model. Rats received either saline, phentolamine, atenolol, or phentolamine plus 
atenolol, 30 minutes before the onset of asphyxia. Electrocardiogram (ECG) and 
electroencephalogram (EEG) signals were simultaneously collected and investigated. We found 
that adrenergic blockade significantly (1) suppressed the initial decline of cardiac output, (2) 
prolonged electrical activities of both the brain and heart, and (3) altered CCCoh and CCCon bi-
directionally and hemispherically. The protective effects of adrenergic blockers paralleled the 
suppression of brain and heart electrical connectivity, especially in the right hemisphere 
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associated with central regulation of sympathetic function. In the second study, we investigated 
corticocardiac coupling in a patient died from cardiac arrest. Consistent with previous findings 
from rats, there was a marked increase of CCCoh and CCCon in the dying patient. However, 
different from rat model, CCCoh and CCCon in human patient showed changes unique to 
individual cortical channels and limited to particular frequency ranges. We also identified a surge 
of cardiac event-related potential at near-death in the right prefrontal and left occipital cortical 
region, which have been shown to play a role in autonomic control of the heart. In studies 1 and 
2, we investigated corticocardiac coupling in sudden death induced by asphyxia that affects both 
the heart and the brain, or cardiac abnormalities. In the third project, we investigated 
corticocardiac coupling in forebrain ischemic stroke-induced sudden cardiac arrest rat model. 
EEG and ECG signals were simultaneously collected from 9 spontaneously hypertensive stroke-
prone rats (SHRSP) and 8 Wistar-Kyoto (WKY) rats. Forebrain ischemic stroke resulted in 
100% mortality in SHRSP rats within 14 hours, whereas no mortality was observed in control 
WKY rats. The functionality of both the brain and the heart were significantly altered in SHRSP 
compared to WKY rats after forebrain ischemia. In contrast to WKY rats, SHRSP rats exhibited 
intermittent surge of CCCoh, which was in parallel with elevated CCCon and reduced heart rate 
variability before sudden death, suggesting that an elevated brain-heart coupling is consistently 
associated with the disruption of the autonomic nervous system and the risk of sudden death. 
Results from these three studies suggest that strong corticocardiac coupling may be a 
shared mechanism for sudden cardiac arrest in both rat models and human patients. This study 
could improve our understanding on the mechanism underlying sudden cardiac arrest, and may 
provide important information for prevention of sudden death. 
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Chapter 1 Introduction 
 
1.1 Sudden cardiac arrest 
Sudden cardiac death is defined as the unexpected natural death due to cardiac causes, heralded 
by abrupt loss of consciousness within 1 hour of the onset of acute symptoms or, if unwitnessed, 
within 24 hours of last being seen alive, in patients with or without preexisting heart diseases 
[Zipes, et al., 2006; Myerburg and Castellanos, 2015]. Sudden cardiac arrest is a leading cause of 
death in the United States and other countries. The overall survival rate of sudden cardiac arrest 
was found to be 4.6% in a North American analysis [Nichol et al., 2008]. In the United States 
alone, about 300,000 to 400,000 people of all ages experience sudden cardiac death each year, 
which accounts for approximately 5.6% of all causes of deaths [Stecker et al., 2014]. The 
incidence of sudden cardiac death is higher in male (76 per 100,000 population) than female (45 
per 100,000 population) [Stecker et al., 2014]. In male, the incidence of sudden cardiac death 
exceeds many other causes of death, which includes lung cancer, prostate cancer, colorectal 
cancer, accidents, chronic lower respiratory disease, cerebrovascular disease, and diabetes 
mellitus (Table 1.1) [Stecker et al., 2014]. The incidence of sudden cardiac death in female is 
similar to lung cancer, cerebrovascular disease, and chronic lower respiratory disease, and is 
higher than that of many other causes of death, including breast cancer, colorectal cancer, 
Alzheimer disease, and accidents (Table 1.1) [Stecker et al., 2014]. The high incidence and 
mortality of sudden cardiac arrest among a variety of common diseases and cancers suggest that 
it remains a major public health problem.   
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Table 1.1 Mortality for sudden cardiac death, cancers, and common diseases. [modified from Stecker et 
al., 2014] 
Disease Male Female 
 No. of death Death rate No. of death Death rate 
Sudden cardiac death 114,948  
(99,722-131,505) 
76  
(66-87) 
69,524 
(58,152-82,294) 
45 
(37-53) 
Lung cancer 88,527 59 70,040 45 
Prostate*/Breast cancer# 28,464 19 40,576 26 
Colorectal cancer 26,923 18 25,918 17 
Cerebrovascular disease 52,073 35 79,769 49 
Chronic lower respiratory disease 65,119 43 72,234 46 
Diabetes mellitus*/ 
Alzheimer disease# 
35,054 23 54,916 35 
Accidents 75,022 50 42,999 28 
*Only applicable to male, #only applicable to female, death rates are expressed per 100,000 national male 
or female population, parenthesis shows 95% confidence intervals. 
Sudden cardiac death has a multitude of potential etiologies. It has been estimated that 
nearly 50% of people with sudden cardiac arrest has no previously diagnosed heart diseases 
[Stecker et al., 2014]. In patients aged 50 years and above, coronary artery disease and ischemic 
cardiomyopathy are the predominant causes of sudden cardiac death [Israel, 2014]. However, 
study in young patients (< 35 years) showed that sudden cardiac death may occur in patients with 
structurally normal heart (Figure 1.1) [Papadakis et al., 2009]. Central nervous system disorders 
including epilepsy, ischemic stroke, intracranial bleeding, and traumatic head injury can result in 
sudden cardiac death [Finsterer and Wahbi, 2014]. Although the detailed physiological 
mechanism is unknown, it has been speculated that these cerebral abnormalities induce 
catastrophic cardiac events like severe bradycardia, ventricular tachycardia (VT), and ventricular 
fibrillation (VF), and eventually lead to sudden cardiac death through the disruption of the 
autonomic nervous system [Finsterer and Wahbi, 2014]. In addition to neurological disorders, 
asphyxia induced by drowning, abnormalities of breathing/statues asthmatics, or choking could 
also lead to sudden cardiac death [Papadakis et al., 2009]. The multifactorial properties of 
sudden cardiac death make its prediction, prevention, and management a challenging task.  
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Figure 1.1 Causes of sudden cardiac death expressed as percentage of the total number of possible 
cardiac death in 433 young people. SIDS: sudden infant death syndrome. [Papadakis et al., 2009] 
1.2 Conventional view on the mechanism of sudden cardiac arrest 
As cardiac arrhythmias, including VT, VF, pulseless electrical activity (PEA), and asystole, are 
frequently the last events before death, the mechanisms causing these arrhythmias are often 
considered as the predominant mechanisms underlying sudden cardiac arrest [Israel, 2014]. 
Consequently, many current pharmacological treatments which include anti-ischemic 
interventions and heart failure therapies are targeting on the electrophysiological substrate or 
mechanisms that cause these detrimental arrhythmias. Although beneficial to patients who had 
advanced chronic heart diseases [Israel, 2014], these therapies have proven unsuccessful when 
applied to high or moderate risk patients without prior documented clinical arrhythmias 
[Fishman et al., 2010]. In addition, there is also no effective strategies for the prevention of 
sudden cardiac death. The combination of implantable cardioverter-defibrillator (ICD) with heart 
failure drug therapy is the main approach for sudden cardiac death prevention [Moss et al., 2002; 
Bardy et al., 2005], but is likely to benefit only the small population who can be identified at 
high risk for sudden cardiac arrest [de Vreede-Swagemakers et al., 1997; Stecker et al., 2006]. 
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For low-risk individuals without established heart disease, which comprise the largest proportion 
of sudden cardia death, there is no effective preventive strategies available [Cupples et al., 1992; 
Albert et al., 2003; Gorgels et al., 2003].  
The lack of effective methodologies for the prediction and prevention of sudden cardiac 
arrest may due to two major gaps with current research on sudden cardiac arrest: 1) The lack of 
clear understanding on the mechanism of sudden cardiac arrest. As sudden cardiac arrest could 
be induced by either abnormality with the heart (cardiovascular diseases), the brain (neurological 
disorders), or both the brain and the heart (asphyxia), it is possible that these detrimental cardiac 
arrhythmias are the indirect cause of sudden cardiac death. Simply focusing on these terminal 
arrhythmias may prevent us from identifying the most fundamental causes of sudden cardiac 
death. 2) The lack of novel research tools to investigate the mechanism underlying sudden 
cardiac arrest. Most current studies are investigating molecular and cellular events that happen 
on large time scale, like hours or days. To study sudden death events that occur within minutes 
or seconds, more advanced tools that could measure electrophysiological processes that happen 
on short time scale are needed.  
1.3 New hypothesis on the mechanism of sudden cardiac arrest 
1.3.1 The concept of brain-heart connection 
A growing body of evidence from both psychological studies in healthy subjects and studies on 
neurocardiological diseases suggest that there might be a tight connection between the brain and 
the heart. The bidirectional brain-heart connection could be conceptualized from two 
perspectives: 1) The heart’s effects on the brain. In normal physiological conditions, heartbeat 
evoked potential has been consistently detected in the cortical signals of subjects when 
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performing behavioral tasks [Gray et al., 2007; Baranauskas et al., 2017]. In disease conditions, 
cardiac arrhythmias could trigger neurological response, such as the sensation of cardiac pain. 2) 
The brain’s effects on the heart. In normal conditions, activities such as yoga and meditation 
could lead to decrease in heart rate via activation of the vagus nerve [Kubota et al., 2001; Vinay 
et al., 2016]. In addition, fearful visual images, processed centrally, are well known to impact 
cardiac functions by elevating heart rate [Hagenaars et al., 2015]. In disease conditions, brain 
disorders such as stroke could induce cardiac arrhythmias or myocardial injury, and lead to 
sudden death via autonomic imbalance [Oppenheimer et al., 1991; Soros and Hachinski, 2012; 
Finsterer and Wahbi, 2014]. Through transneuronal labeling, functional magnetic resonance 
imaging (fMRI), and cortical stimulation studies, several forebrain regions, including the 
prefrontal cortex, insular cortex, cingulate cortex, and other subcortical and brainstem nuclei 
have been showed to send projections to cardioregulatory center and may be involved in 
moment-to-moment modulation of cardiac functions (Figure 1.2) [Palma and Benarroch, 2014].  
 
Figure 1.2 Efferent and afferent control of cardiac function. ACC: anterior cingulate cortex, PAG: 
periaqueductal gray, DVN: dorsal vagal nucleus, IML: intermediolateral, LC: locus ceruleus, PG: petrosal 
ganglion, NG: nodose ganglion, DRG: dorsal root ganglia. [Palma and Benarroch, 2014] 
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Though the concept of brain-heart connection has been brought up for years and 
abnormal brain-heart connection has been associated with many diseases like neurogenic heart 
diseases, cardiac source embolic stroke, and neurocardiac syndromes [Samuels, 2007], 
mechanism by which cortical neural circuitry affects cardiac function in normal and disease 
conditions remains unclear. In sudden cardiac arrest models, brain-heart connection has not been 
investigated comprehensively. It is generally believed that the brain does not play an active role 
during sudden cardiac arrest. This is partially due to several early studies in cardiac arrest animal 
models, which showed that EEG activity disappeared earlier than ECG signals during cardiac 
arrest (Figure 1.3) [Komura and Fujimura, 1974]. As a measurement of the electrical activity of 
the brain, the early termination of EEG than ECG was interpreted as the cessation of cortical 
functional activity before the devastating cardiac events. Thus, the brain was not considered to be 
involved in the dying process. Similar results have been obtained in several other sudden cardiac 
arrest animal models [Tisherman et al., 1985; Eshel et al., 1990; Coenen et al., 1995]. These data 
further strengthen the concept that brain damage occurs more rapidly than cardiac asystole and 
should not play a role in mediating sudden death. 
 
Figure 1.3 EEG and ECG from rabbits suffered from asphyxia by respiratory arrest. Cm: cortex 
sensitivo-motorius, surface EEG; RF: reticular formation, deep EEG. [Komura and Fujimura, 1974] 
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1.3.2 A well-organized series of high-frequency activity discovered in the brain after 
cardiac arrest 
To systematically investigate the neurophysiological state of the brain following cardiac arrest, 
we performed continuous EEG and ECG recording in rats undergoing experimental cardiac 
arrest induced by intracardiac injection of KCl [Borjigin et al., 2013]. We identified a well-
organized series of high-frequency activity in the brain after the heart stops (Figure 1.4). As 
shown in panel A, all signals seem to be isoelectric immediately after cardiac arrest. However, if 
we zoom in a 40-second-long epoch before and after cardiac arrest, as shown in panel B, we 
found that ECG signals stopped right after cardiac arrest, whereas EEG signals maintained 
normal amplitude for 3 seconds before transitioning to low-amplitude oscillations that lasted for 
about 30 seconds. According to its features, this cardiac arrest (CA) period was divided into 4 
sequential and distinctive stages: CAS1, CAS2, CAS3, and CAS4. Further zoom in of these 4 
representative stages after cardiac arrest revealed unique features associated with EEG signals. 
As shown in panel C, EEG signals showed marked increase in gamma oscillations in all 6 
channels in CAS1. CAS2 displayed theta oscillations coupled with high-frequency gamma  
Figure 1.4 EEG displays a well-organized series of high-frequency activity following cardiac arrest. RF: 
right frontal, LF: left frontal, RP: right parietal, LP: left parietal, RO: right occipital, LO: left occipital, 
CAS: cardiac arrest stage. [Borjigin et al., 2013] 
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oscillations across all 6 channels. CAS3 is dominated by low-gamma oscillations that were 
highly synchronous. In CAS4, EEG signals become isoelectric. It is known that gamma signals 
are associated with waking consciousness, altered states of consciousness during meditation, and 
rapid eye movement (REM) sleep [Llinas and Ribary, 1993; Lutz et al., 2004; Fries, 2009; Cahn 
et al., 2010; Buzsaki and Wang, 2012]. Theta oscillations are important for synaptic plasticity, 
information coding, and working memory [Benchenane et al., 2010; Molter et al., 2012]. The 
significant increase in theta and gamma oscillations indicates that there are internally highly 
activated functional activities in the brain, even after the heart stops beating. Further analysis of 
EEG signals using advanced signal processing techniques, which include functional connectivity 
(coherence), effective (directional) connectivity, and cross-frequency coupling, demonstrates that 
there are high level of interregional coherence and feedback connectivity as well as cross-
frequency coupling within the brain at near-death. In contrast to the conventional view that the 
brain is extremely quiet in the dying process, our data strongly suggest that the brain is highly 
aroused during cardiac arrest.  
This study showed for the first time that the brain is highly activated during cardiac 
arrest. To future investigate the role of a highly activated brain in the dying process and its 
potential interaction with the heart, we performed a follow-up study [Li et al., 2015]. In that 
study, EEG and ECG signals were collected and analyzed in an asphyxic cardiac arrest model 
induced by CO2 inhalation, which is the most common method of euthanasia for rats, mice, and 
many other small rodents. Different from KCl injection-induced cardiac arrest model used in 
previous study, in which the activity of the brain was measured when the cardiac activity was 
stopped, asphyxic cardiac arrest model allowed us to study the time-dependent deterioration of 
the brain and the heart at the same time. By simultaneous recording of EEG and ECG signals in 
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rats before and after asphyxia, possible interactions between the brain and the heart during 
cardiac arrest could be investigated. 
1.3.3 A surge of corticocardiac coupling during asphyxia-induced sudden cardiac arrest 
The electrical signal coupling and communication both within the brain and between the brain 
and the heart during asphyxic cardiac arrest were studied using coherence and directional 
connectivity analysis. While coherence is a well-established method to study the synchronization 
between electrical signals from two different brain loci, directional connectivity is widely used to 
investigate the causal information flow between two or more signals [Lee et al., 2009; Borjigin et 
al., 2013; Li et al., 2015]. We found that asphyxia stimulated a marked surge of coherence and 
directional connectivity both within the brain and between the brain and the heart during 
asphyxic cardiac arrest (Figure 1.5). As shown in panel A, heart rate changes exhibited four 
distinct phases A1, A2, A3, and A4 after CO2 administrated at time 0. Immediately following 
Figure 1.5 A surge of 
coherence and connectivity 
both within the brain and 
between the brain and the 
heart during asphyxic cardiac 
arrest. RRI: RR interval (A), 
CCoh: cortical coherence (B), 
CCon: cortical directional 
connectivity (C), CCCoh: 
corticocardiac coherence (D), 
CCCon: corticocardiac 
directional connectivity (E), 
NSTE: normalized symbolic 
transfer entropy, red trace in 
panel C: frontal to 
parietal/occipital, blue trace in 
panel C: occipital/parietal to 
frontal, red trace in panel E: 
brain to heart, blue trace in 
panel E: heart to brain, alpha: 
10-15Hz. [modified from Li et 
al., 2015] 
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asphyxia, there is a rapid increase of RR interval (RRI) followed by a complete recovery in A1 
and a second surge of RRI followed by an incomplete recovery in A2. In parallel with the 
response of the heart to asphyxic challenge, the brain displayed intense coherent patterns (CCoh) 
in A1 and A2, especially for high frequency gamma rhythms, which are often associated with 
cognition and conscious perception (Figure 1.5B) [Panagiotaropoulos et al., 2012; Cavinato et 
al., 2015]. The lack of corticocardiac coherence (CCCoh) and corticocardiac directional 
connectivity (CCCon) during earlier stages of A1 and A2 suggest that there is no signal 
communication between the cortex and the heart in these early phases (Figure 1.5D and 1.5E). 
The immediate surge of high frequency CCoh and the dramatic fluctuations of RRI in A1 and A2 
may be regulated by subcortical mechanisms. After this early phase of asphyxia, severe 
bradycardia with mild fluctuation of RRI is observed in A3 (Figure 1.5A). Interestingly, strong 
CCCoh, indicator for intense brain and heart electrical signal synchronization, appeared during 
this stage (Figure 1.5D). In addition, increased CCCon was also identified in A3, with the 
information flow from the brain to the heart dominants (Figure 1.5E). Based on these results, we 
postulated the following hypotheses: (1) Immediately after asphyxia onset, the heart may strive 
to restore its normal function using autonomic feedback loop; (2) When the autonomic feedback 
is insufficient to restore the normal function of the heart, as shown by the incomplete recovery of 
RRI in A2, the brain suspends all non-essential functions, and focuses on restoring basic cardiac 
function that is more fundamental for survival; (3) The ineffective restoration of RRI in A3 
subsequently stimulated a more robust activation of the brain and corticocardiac coupling at 
higher frequency, which then triggered the onset of VT and VF in A4. The sequential changes of 
RRI, CCon, CCoh, CCCon, and CCCoh demonstrate that asphyxia activates a programmed surge 
of cortical activity and coupling between the brain and the heart during asphyxic cardiac arrest.  
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1.3.4 A dramatic release of cortical neurotransmitters during asphyxia-induced sudden 
cardiac arrest 
To investigate the neurochemical basis of the increased cortical activities during cardiac arrest, 
microdialysis was performed in the frontal and occipital lobes of the rats before and after 
asphyxia. The results of 6 chemicals are shown in Figure 1.6. As expected, levels of glucose 
dropped rapidly within 2 minutes of asphyxia. A significant surge of secretion was detected for 
all 5 neurotransmitters, which includes adenosine, dopamine, norepinephrine, serotonin, and 
GABA. These neurotransmitters are known to be involved in the regulation of brain functional 
activities, such as arousal, attention, cognition, and hallucination [Inada et al., 1996; Espana et 
al., 2016; Carr et al., 2017]. Some of them are also involved in the regulation of cardiac  
functions. For example, elevated central norepinephrine is thought to act within the brainstem to  
 
 
 
 
 
 
 
 
Figure 1.6 Asphyxia stimulated an immediate and marked surge of cortical neurotransmitter. Red tracing: 
frontal lobe, blue tracing: occipital lobe, star: significant increase over baseline, pound: significant 
difference between frontal and occipital lobes. [Li et al., 2015] 
inhibit parasympathetic cardiac vagal neurons [Boychuk et al., 2011]. Serotonin plays an 
important role in the regulation of cardiovascular reflexes [Ramage and Villalon, 2008]. It has 
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been shown that overexpression of serotonin auto-receptor in the raphe complex results in 
autonomic dysregulation [Audero et al., 2008]. GABA release is known to be associated with the 
increased sympathetic tone and the inhibition of parasympathetic vagal neurons projecting to the 
heart [Zhong et al., 2008; Wang et al., 2010; Bowman and Goodchild, 2015]. The dramatically 
increased release of cortical neurotransmitters that are involved in the regulation of cardiac 
function suggests that the brain may play an important role in the regulation of the heart during 
asphyxic cardiac arrest. Although the detailed mechanisms of how the marked increase of 
neurotransmitter release after asphyxia mediates sudden cardiac arrest are still unknown, these 
data at least provide the neurochemical evidence to support that the brain actively participates in 
the regulation of cardiac functions during asphyxic cardiac arrest.  
1.3.5 Cutting brain-heart connection prolongs survival after asphyxic cardiac arrest 
Based on results from Figure 1.5 and Figure 1.6 that there is increased cortical functional activity 
and surge of key cortical neurotransmitters during asphyxic cardiac arrest, we hypothesize that 
the brain may play an important role in the dying process. To test this hypothesis, we studied the 
survival time for both the heart and the brain after disconnecting the heart from the brain using 
two approaches: 1) C7 transaction (C7X), which is spinal cord transection at cervical level 7. 
This surgery terminates all the sympathetic outflows traveling down the spinal cord. 2) Blockade 
of parasympathetic action using atropine. In this experiment, rats received C7X or sham surgery 
were treated without or with atropine 30 minutes before the onset of asphyxia. We found 
significantly longer survival time of both the heart (increased duration of ECG signal) and the 
brain (increased duration of CCoh) in rats received C7X, but this effect was not significantly 
affected by the injection of atropine (Figure 1.7) [Li et al., 2015]. These data indicate that 
asphyxia-stimulated brain-heart signaling during cardiac arrest is mediated mainly by the 
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sympathetic nervous system and the blockade of sympathetic nerves may be an effective 
approach to delay the death of both the heart and the brain.  
 
Figure 1.7 C7 transection prolongs the survival of both the heart and the brain during asphyxia cardiac 
arrest. C7X: C7 transection, **p < 0.01. [Li et al., 2015] 
In contrast, sympathetic agonist epinephrine is currently the primary drug administered 
during cardiopulmonary resuscitation to reverse cardiac arrest [Hermreck, 1988; Field et al., 
2010]. Epinephrine has been used to resuscitate patients for 120 years and is recommended in 
American Heart Association (AHA) guidelines for advanced cardiovascular life support 
[Morrison et al., 2010; Neumar et al., 2010]. The addition of epinephrine into the guideline 
dramatically increases the number of patients who were given epinephrine. However, despite its 
long time use and incorporation into guidelines, epinephrine suffers from a lack of evidence 
regarding its effects on survival. A recent paper, reviewing 6 studies investigating whether 
epinephrine provides any overall benefits for patients, demonstrates that epinephrine 
administered during cardiac arrest has no benefit or even harmful effects for improving cardiac 
outcomes [Callaway, 2013]. There are also studies that showed that the use of epinephrine is 
significantly associated with decreased chance of survival and negative neurological outcomes 
[Herlitz et al., 1995; Stiell et al., 2004; Ohshige et al., 2005; Olasveengen et al., 2009; Hagihara 
et al., 2012]. These studies led us to conclude that stimulating the sympathetic nervous system 
14 
 
does not improve, but harm both the brain and the heart. Blockade of sympathetic nervous 
system may be the right approach to save the heart and the brain.  
1.3.6 New hypothesis: corticocardiac coupling as a mechanism for sudden cardiac arrest 
Based on the above discussion, we proposed a new mechanism for sudden cardiac arrest. 
Different from the conventional view that the brain is hypoactive during sudden cardiac arrest, 
our data strongly suggest that the brain plays an active role in mediating the dying process. This 
is supported by the robust and sustained activation of functional and effective connectivity within 
the brain, immediate and marked surge of a set of cortical neurotransmitters, and delayed 
activation of functional coupling and electrical signal communication between the brain and the 
heart at near-death. Instead of playing a passive role, we proposed that the brain plays an active 
role in mediating the dying process by sending strong electrical signals to resuscitate the heart, 
which unintentionally causes premature and rapid deterioration of the cardiac function via the 
over-activated sympathetic nervous system. Blockade of sympathetic signaling significantly 
delayed the death of both the heart and the brain and may become a promising approach for 
preventing sudden cardiac arrest and extending survival. 
1.4 Overview of thesis project 
As a follow-up of two previous studies [Borjigin et al., 2013; Li et al., 2015], the current thesis 
continued to investigate the mechanism of corticocardiac coupling in different sudden cardiac 
arrest models using advanced signal processing approaches. In Li et al., 2015, using C7X, we 
showed for the first time that activated brain sends harmful signals to the heart via the over-
activated sympathetic nervous system. Since C7X is an invasive surgery, in Chapter 2, we tested 
if pharmacological blockade of sympathetic nervous system using alpha and beta blockers could 
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reproduce the results obtained from C7X in the same asphyxic cardiac arrest rat model (Figure 
1.8). As sudden cardiac arrest could also be induced by abnormalities in the heart or neurological 
diseases, in addition to KCl injection-induced cardiac arrest rat model [Borjigin et al., 2013] and 
asphyxia-induced cardiac arrest rat model [Li et al., 2015], we studied corticocardiac coupling in 
two other models. In Chapter 3, we tested if corticocardiac coupling exist in human patient 
suffered from cardiac arrest. In Chapter 4, we investigated corticocardiac coupling in forebrain 
ischemic stroke-induced sudden cardiac arrest rat model. The understanding on the mechanism 
of corticocardiac coupling during sudden cardiac arrest is still in its early stage. Through this 
thesis project, we hope to establish that elevated corticocardiac coupling may be a basic common 
mechanism for sudden cardiac arrest induced by different causes and that the blockade of 
efferent sympathetic signaling is a potential effective strategy to prevent sudden cardiac arrest. 
This study is expected to have significant clinical impact, because it would build a new 
framework for understanding sudden cardiac arrest associated with different causes and for the 
development of effective strategies to prevent sudden cardiac arrest.  
 
Figure 1.8 Overview of thesis project. Chapter 2: corticocardiac coupling in asphyxia-induced sudden 
cardiac arrest rat model. Chapter 3: corticocardiac coupling in a human patient died from cardiac arrest. 
Chapter 4: corticocardiac coupling in forebrain ischemic stroke-induced sudden cardiac arrest rat model.  
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Chapter 2 Adrenergic blockade bi-directionally and asymmetrically alters functional 
brain-heart communication and prolongs electrical activities of the brain and heart during 
asphyxic cardiac arrest 
2.1 Introduction 
Fatal cardiac arrest affects more than 400,000 Americans each year [Chugh et al., 2008; Stecker 
et al., 2014]. Despite decades of intensive research efforts, survival rate from cardiac arrest is 
only about 5% [Nolan et al., 2012; Stecker et al., 2014]. Sudden death occurs in patients with 
cardiovascular disease as well as those with no known history of heart disease, including 
individuals with ischemic stroke, traumatic brain injury, epilepsy, chronic obstructive pulmonary 
disease, and asphyxia [Samuels, 2007; Sörös and Hachinski, 2012; Israel, 2014; Lahousse et al., 
2015]. Unfortunately, current studies of cardiac arrest are largely focused on the cardiovascular 
pathology and methods of cardiac resuscitation; very little attention has been given to the role of 
the brain prior to the arrest of the heart.  
Recent studies from our laboratory demonstrate that the brain plays a key role in cardiac 
arrest. Experimental cardiac arrest [Borjigin et al., 2013] and asphyxic cardiac arrest [Li et al., 
2015a] both lead to a rapid surge of functional connectivity (coherence) and effective 
connectivity in the dying brain. The marked surge of cortical coherence (CCoh) and directional 
cortical connectivity  (CCon) paralleled dramatically increased release of a set of core 
neurotransmitters in the brain [Li et al., 2015a]. Importantly, asphyxia activates a delayed surge 
of cortex-heart coupling, a novel form of communication measured by corticocardiac coherence 
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(CCCoh) and directional corticocardiac connectivity (CCCon) [Li et al., 2015a]. We 
hypothesized that the stimulated brain functions to resuscitate the heart internally by activating 
the sympathetic nervous system [Li et al., 2015a], the main mechanism thought to lead to sudden 
cardiac arrest in high risk patients [Samuels, 2007; Dhalla et al., 2010]. Past studies have shown 
that experimental cardiac arrest stimulates excessive neural release of catecholamines leading to 
fatal ventricular arrhythmias [Foley et al., 1987; Borovsky et al., 1998; Dhalla et al., 2010]. 
Consistent with these reports, a marked surge of cardiac sympathetic activity was reported in 
patients with sustained ventricular arrhythmias [Meredith et al., 1991]. These data demonstrate 
that increased cardiac sympathetic activity is causally linked with cardiac failures [Samuels, 
2007; Taggart et al., 2011; Silvani et al., 2016]. 
Beta blockers (blockers of beta-adrenergic receptors) are widely used to manage cardiac 
arrhythmias and to prevent a second myocardial infarction in heart attack patients [Yusuf et al., 
1985; Freemantle et al., 1999; Bourque et al., 2007] and are shown to reduce the incidence of 
ventricular fibrillation (VF) after acute myocardial infarction [Rydén et al., 1983; Norris et al., 
1984]. Despite the mounting evidence for the positive effects of beta blockers to protect diseased 
hearts, the mechanism by which beta-blockers prevent ventricular arrhythmias is not well 
understood [Yusuf et al., 1985; Bourque et al., 2007].  
In our earlier study [Li et al., 2015a], surgical blockade of efferent neuronal outflows 
travelling down the spinal cord below the cervical level 7 (C7) significantly extends the electrical 
activities of both the heart and the brain in the dying rats. Since sympathetic signals exit the 
spinal cord below C7 in rats, the beneficial effects of the C7 transection procedure is likely 
mediated by the blockade of sympathetic impact on the heart. The present study is designed to 
test if and how pharmacological blockade of the adrenergic receptors of the heart influences the 
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cortical oscillations and changes the dynamics of the brain-heart electrical coupling in CO2-
mediated asphyxic cardiac arrest model. 
The sympathetic nervous system regulates the cardiovascular function via both alpha- 
and beta-adrenergic receptors. While alpha- and beta-adrenergic receptor blockers are used 
together to increase efficacy of hypertension treatment [Ram and Kaplan, 1979; Wong et al., 
2015], their combined impact on delaying the onset of cardiac arrest has not been evaluated. In 
this study, we tested the impact of phentolamine (non-selective alpha adrenergic receptor 
blocker) and atenolol (selective beta-1 adrenergic receptor blocker), alone or combined, on the 
duration of cortical and cardiac electrical activity, CCoh, CCCoh, and CCCon in asphyxic rats. 
2.2 Materials and methods 
2.2.1 Animals 
Inbred male Fischer 344 rats from Harlan were acclimatized in our housing facility for at least 1 
week before surgical implantation of electrodes. After implantation, rats were allowed to recover 
for at least 1 week before online recording. All experiments were conducted using adult rats 
(300-400 g) maintained on a light: dark cycle of 12: 12 hour and provided with ad libitum food 
and water. This study was carried out in accordance with the recommendations of the University 
of Michigan Committee on Use and Care of Animals. The protocol was approved by the 
University of Michigan Committee on Use and Care of Animals.  
2.2.2 Electrode implantation and configuration 
Rats were implanted with electrodes for ECG and EEG recording under surgical anesthesia 
[1.8% (vol/vol) isoflurane]. ECG was recorded through flexible and insulated multi-stranded 
wires (Cooner Wire) inserted into the subcutaneous muscles flanking the heart. EEG was 
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recorded through screw electrodes implanted bilaterally on the frontal [anteroposterior (AP): + 
3.0 mm; mediolateral (ML): ± 2.5 mm, bregma], parietal (AP: -3.0 mm; ML ± 2.5 mm, bregma), 
and occipital (AP: -8.0 mm; ML: ± 2.5 mm, bregma) cortices. A nose electrode was used as the 
EEG reference (Borjigin et al., 2013). The ECG and EEG electrodes were interfaced with two 
six-pin pedestals (Plastics One) and secured on the skull with dental acrylic. 
2.2.3 Signal acquisition 
Before data collection, rats were acclimatized overnight in the recording chamber. ECG and 
EEG were recorded using Grass Model 15LT physiodata amplifier system (15A54 Quad 
amplifiers, Astro-Med, Inc.) interfaced with BIOPAC MP-150 data acquisition unit and 
AcqKnowledge software (version 4.1.1, BIOPAC Systems, Inc.). Signals were filtered between 
0.1 and 300 Hz and sampled at 1,000 Hz. ECG and EEG recordings were initiated consistently at 
10:00 am to control for circadian factors. The rats were divided into 4 groups. Baseline signals 
were recorded for at least 30 minutes for all the rats. Then each group of rats received either 
saline (n=10), phentolamine (10mg/kg, n=7), atenolol (10mg/kg, n=8), or phentolamine plus 
atenolol (10mg/kg, 10mg/kg, n=11). Thirty minutes after drug injection, cardiac arrest was 
induced by inhalation of CO2 (30%) for 2 minutes. Recording was continued for another 30 
minutes after asphyxia. 
2.2.4 Analysis of RR interval (RRI) and cardiac arrhythmias 
To analyze the RRI (the time intervals between the R-peaks of two adjacent heartbeats), baseline 
drift correction was first implemented using second-order Butterworth high-pass filtering with a 
cutoff frequency at 1 Hz (butter.m and filtfilt.m in Matlab Signal Processing Toolbox; 
MathWorks Inc.). R-peak of ECG signals was then detected using variable threshold method 
[Kew and Jeong, 2011]. Specifically, an amplitude threshold in each nonoverlapping 1 s epoch 
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was applied to select the candidates for R peaks, which can be verified only if the RRI value 
exceeds a predefined threshold. In this study, the interval threshold was selected as half of the 
median value of the RRI values in the last 1 s epoch. The automatically detected R peaks were 
manually validated through a custom user interface developed in Matlab (MathWorks Inc.). To 
analyze the number and types of cardiac arrhythmias, ECG signals were examined and cardiac 
arrhythmias were manually labeled using a custom user interface developed in Matlab 
(MathWorks Inc.). 
2.2.5 Construction of electrocardiomatrix (ECM) 
The ECM is designed to facilitate the visualization of RRI, the amplitude, and the morphology of 
ECG signals. For construction of ECM [Li et al., 2015b], a window centered on the detected 
ECG R peaks (for example, from - 0.1 s to 0.3 s, with 0 corresponding to the time of R-peak) 
was extracted from the ECG signal after baseline drift correction. All ECG windows were sorted 
according to the order of R-peak time and then plotted as parallel colored lines to form a colored 
rectangular image. The intensity of ECG signal was denoted on z-axis, with warmer color 
indicates positive peaks with higher voltage, while cooler color indicates negative peaks with 
lower voltage. The color scheme could be adjusted according to the need. 
2.2.6 Analysis of CCoh and CCCoh 
The coherence between six EEG channels (CCoh) or between one ECG and each of the six EEG 
channels (CCCoh) were measured by amplitude squared coherence (𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓)) (mscohere.m in 
Matlab Signal Processing Toolbox; MathWorks Inc.), which is a coherence estimate of the input 
signals x and y using Welch’s averaged, modified periodogram method. The magnitude squared 
26 
 
coherence 𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) is a function of frequency with values between 0 and 1 that indicates how well 
signal x corresponds to signal y at each frequency.  
𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) = �𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓)�2𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓)𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓), 0 ≤ 𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) ≤ 1   (1) 
where 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) and 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) are the power spectral density of x and y, and 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) is the cross power 
spectrum spectral density. 
In current study, electrophysiological signals were first segmented into 2 s epochs with 1 
s overlap. The magnitude squared coherence was then calculated at each epoch and frequency 
bin (from 0.5 to 250 Hz). Before coherence analysis, a notch filter was used to remove the 60 Hz 
artifact and its possible super-harmonics. For each rat, the mean coherence among 15 pairs of six 
EEG channels (Figure 2.2A), the mean coherence among one ECG and six EEG channels 
(Figure 2.5A), as well as the coherence between one ECG and each of the six EEG channels (6 
pairs; Figure 2.6A) were calculated and plotted for frequencies from 0.5 to 250 Hz. The mean 
and standard deviation (SD) of coherence between one ECG and six EEG channels (Figure 2.5B) 
and the coherence between one ECG and each of the six EEG channels (Figure 2.6B) were 
calculated for frequencies from theta to gamma 1 (theta: 5-10 Hz, alpha: 10-15 Hz, beta: 15-25 
Hz, and gamma 1: 25-55 Hz). 
2.2.7 Analysis of CCCon 
The directional connectivity between the heart and brain (or between one ECG and each of the 
six EEG channels, CCCon) was measured by a modified [Li et al., 2015a] Normalized Symbolic 
Transfer Entropy (NSTE) method [Lee et al., 2009], which is a nonlinear and model-free 
estimation of directional functional connection based on information theory. STE denotes the 
amount of information provided by the additional knowledge from the past of the source signal 
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X (𝑋𝑋𝑃𝑃) in the model describing the information between the past Y (𝑌𝑌𝑃𝑃) and the future Y (𝑌𝑌𝐹𝐹) of 
the target signal Y, which is defined as follows: 
𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌 = 𝐼𝐼(𝑌𝑌𝐹𝐹;𝑋𝑋𝑃𝑃|𝑌𝑌𝑃𝑃) = 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) − 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑋𝑋𝑃𝑃,𝑌𝑌𝑃𝑃)   (2) 
where 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) is the entropy of the process 𝑌𝑌𝐹𝐹conditional on its past. Each vector for 
𝑌𝑌𝐹𝐹 ,𝑋𝑋𝑃𝑃 𝑎𝑎𝑎𝑎𝑎𝑎 𝑌𝑌𝑃𝑃is a symbolized vector point. The potential bias of STE was removed with a 
shuffled data, and the unbiased STE is normalized as follows:  
𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌
 = 𝑆𝑆𝑆𝑆𝑆𝑆𝑋𝑋→𝑌𝑌−𝑆𝑆𝑆𝑆𝑆𝑆𝑋𝑋→𝑌𝑌𝑆𝑆ℎ𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢 
𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌  ) ∈ [0, 1]   (3) 
where 𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌
𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑢𝑢𝑢𝑢𝑢𝑢 = 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) − 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑋𝑋𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑃𝑃 ,𝑌𝑌𝑃𝑃). 𝑋𝑋𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑃𝑃  is a shuffled data created by 
dividing the data into sections and rearranging them at random. Therefore, NSTE is normalized 
STE (dimensionless), in which the bias of STE is subtracted from the original STE and then 
divided by the entropy within the target signal, 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃). 
For CCCon, the feedback (FB) connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸) was calculated by averaging 
NSTE over six pairs of EEG channels to ECG channel, which are defined as follows: 
𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸 = 1𝑛𝑛𝐸𝐸𝐸𝐸𝐸𝐸 ∑ 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑖𝑖→𝑆𝑆𝐸𝐸𝐸𝐸𝑛𝑛𝐸𝐸𝐸𝐸𝐸𝐸𝑖𝑖=1    (4) 
where 𝑎𝑎𝑆𝑆𝑆𝑆𝐸𝐸 = 6. The feedforward (FF) connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝐸𝐸𝐸𝐸→𝑆𝑆𝑆𝑆𝐸𝐸) from the ECG to six EEG 
channels is vice versa. 
Specifically, we first filtered EEG and ECG signals into 4 frequency bands (theta, alpha, 
beta, and gamma 1) and then segmented the filtered signals into 2 s long epochs with 1 s 
overlapping. The mean CCCon (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸  and 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝐸𝐸𝐸𝐸→𝑆𝑆𝑆𝑆𝐸𝐸) were sequentially calculated 
for each epoch and each frequency band. Three parameters: embedding dimension (𝑎𝑎𝑆𝑆), time 
delay (τ), and prediction time (𝛿𝛿), were required in the calculation. In this study, we selected the 
parameter setting that could yield maximum 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌  by fixing the embedding dimension (𝑎𝑎𝑆𝑆) 
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at 3, and optimizing prediction time 𝛿𝛿 (from 1 to 50, corresponding to 1-50 ms with the sampling 
frequency of 1,000 Hz) and time delay 𝜏𝜏 (1-300 ms). The same procedure was used to 
calculate 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑌𝑌→𝑋𝑋 , provided that the information between two signals is transferred through 
different neuronal pathway. The mean and SD of the averaged CCCon for all 4 frequencies 
among six EEG channels (Figure 2.8) and that for each of the six EEG channels (6 pairs; Figure 
2.9) were calculated and plotted.  
2.2.8 Statistical analysis 
For all of the statistical analyses, Shapiro-Wilk normality test was first implemented to determine 
if the data was normally distributed. To test the differences of ECG duration (defined as the 
duration from the asphyxia onset at time 0 until the onset of isoelectric activity; Figure 2.1B), 
CCoh duration (Figure 2.2B), mean CCoh during A3 phase (Figure 2.3C), RRI change (Figure 
2.5Ab), mean CCCoh (Figure 2.6B) and mean CCCon (Figure 2.8B) among 4 groups of rats, as 
well as the mean CCCoh (Figure 2.6B) and CCCon (Figure 2.8B) among six EEG channels, one 
way ANOVA with Bonferroni post hoc comparisons (for normally distributed data) or Kruskal-
Wallis Test with Mann-Whitney post hoc comparisons (for non-normally distributed data) were 
used. To analyze the correlation between ECG duration and CCoh duration (Figure 2.4), between 
RRI change and ECG duration (Figure 2.5Ba), and between RRI change and CCoh duration 
(Figure 2.5Bb), Pearson (for normally distributed data) or Spearman (for non-normally 
distributed data) correlation analysis was performed. For all the comparisons, p < 0.05 was 
considered as statistically significant. Statistical analyses were carried out in consultation with 
the Center for Statistical Consultation and Research at the University of Michigan. Statistical 
analyses were performed using the software SPSS (version 19.0; IBM SPSS Statistics). 
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2.3 Results 
2.3.1 Adrenergic blockade prolongs cardiac electrical activity during asphyxia 
Cardiac electrical activity was investigated using ECM to facilitate the visualization of dynamic 
temporal changes of RRI and cardiac arrhythmias before and after asphyxia (Figure 2.1A). Raw 
ECG traces of representative rats were also included for traditional viewing (Supplement Figure 
1 in Appendix). Before asphyxia, all 4 groups of rats had relatively stable RRI of about 0.2 sec 
with no cardiac arrhythmias. Following the onset of asphyxia, the RRI exhibited dramatic and 
distinct changes in the four groups of rats. We divided the changes of RRI and cardiac 
arrhythmias into 5 stages (A1 to A5) according to their cardiac features. Immediately following 
the asphyxia onset in saline treated rats (Figure 2.1Aa), RRI began to expand rapidly, from 0.2 
sec at baseline to 0.6 sec at the peak within 10 sec (A1 stage), indicating a rapid onset of 
bradycardia. PR interval lengthened, suggestive of first-degree heart block. Furthermore, T-
waves increased in peak height, and remained high for the entire bradycardia period in all rats. 
The A1 stage was followed by a transient recovery of RRI that lasted for about 20 sec (A2 
stage). During this period, two cardiac features are worth noting: elevated T-wave peak height 
and peak duration and gradually lengthened PR interval. Stages A1 and A2 show similar 
durations among four groups of rats. The rapid increase of RRI at A1 was reproducibly observed 
in rats injected with saline (Figure 2.1Aa) and phentolamine (Figure 2.1Ab), but was less 
prominent in rats received atenolol (Figure 2.1Ac) and phentolamine plus atenolol (Figure 
2.1Ad). T wave elevation was also noted in all 4 groups of rats during the A2 period, but no 
statistical significance was found between the groups. During this early phase of asphyxia, a 
variety of cardiac arrhythmias was identified in all rats, which includes premature atrial 
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contraction, premature junctional contraction, premature ventricular contraction, junctional 
rhythm, and sinus arrhythmias.  
 
Figure 2.1 Adrenergic blockade prolongs cardiac survival. (A) Electrocardiomatrix (ECM) display of 
ECG signals before (50 sec) and after asphyxia in four groups of rats: (a) saline, (b) phentolamine, (c) 
atenolol, and (d) phentolamine plus atenolol. x axis shows time in seconds, y axis shows RR interval 
(RRI; in seconds), and z axis shows signal strength. Warmer color represents higher signal strength. 
Asphyxia was induced by CO2 infusion at time 0 sec. (B) The mean and SD of ECG signal duration after 
asphyxia in four groups of rats: S (saline, n = 10), P (phentolamine, n = 7), A (atenolol, n = 8), and P+A 
(phentolamine plus atenolol, n = 11). Significant differences of ECG signal duration among 4 groups of 
rats are indicated using asterisks. Error bars denote SD (*p < 0.05, **p < 0.01, ***p < 0.001).  
In contrast to the A1A2 period, the duration and cardiac arrhythmias in stages A3 and A4 
varied significantly. During A3, all rats suffered bradycardia due to 2rd or 3rd degree 
atrioventricular blocks with sequential junctional and ventricular escape rhythms. RRI was 
expanded to as long as 1.4 sec (Figure 2.1Ab, stage A3), a 7-fold increase from the baseline 
values of 0.2 sec. This bradycardia period ended in sustained ventricular tachycardia (VT) during 
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A4 and VF during A5 period (not shown in ECM) in rats injected with saline and phentolamine. 
Interestingly, VT and VF were identified in only 1 of the 8 rats (12.5%) injected with atenolol 
and 2 of the 11 rats (18.2%) received phentolamine plus atenolol (Table 2.1). When VT and VF 
were blocked by these drugs, rats entered an isoelectric stage directly from the A3 stage, 
exhibiting 3rd degree heart block with ventricular escape beats. This result is consistent with the 
reported ability of beta blocker to reduce the incidence of ventricular arrhythmias in human 
patients [Patterson and Lucchesi, 1984; Bourque et al., 2007]. 
Table 2.1 Summary of ventricular tachycardia and ventricular fibrillation in four groups of asphyxic rats. 
 
Saline 
(n=10) 
Phentolamine 
(n=7) 
Atenolol 
(n=8) 
Phentolamine  
+ Atenolol (n=11) 
V. Tachycardia 10/10 (100%) 7/7 (100%) 1/8 (12.5%) 2/11 (18.2%) 
V. Fibrillation 10/10 (100%) 7/7 (100%) 1/8 (12.5%) 2/11 (18.2%) 
To investigate the effects of adrenergic blockade on cardiac electrical activity, we 
compared the duration of ECG signals (that begins from the asphyxia onset to the beginning of 
the isoelectric state) in four groups of rats: saline (305 ± 45 sec; mean ± SD), phentolamine (389 
± 72 sec), atenolol (532 ± 145 sec), and phentolamine plus atenolol (723 ± 304 sec). We found a 
significant increase in the duration of ECG signals in rats received drugs (Figure 2.1B). 
Remarkably, rats received phentolamine plus atenolol had the most significant increase in the 
duration of ECG signals (p < 0.001). 
2.3.2 Adrenergic blockade prolongs cortical functional connectivity  
Cortical coherence (CCoh) was calculated before and after asphyxia (Figure 2.2). In all rats, 
EEG signals displayed intense coherence immediately after asphyxia for high gamma waves (> 
150 Hz) and for theta waves. In addition, three distinct coherence clusters were noted in all rats: 
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gamma 3 (125-175 Hz), gamma 2 (65-115 Hz), and gamma 1 (25-55 Hz). Of these clusters, 
gamma 2 and 3 clusters occurred at the transitions between A1 and A2 stages, whereas the 
gamma 1 cluster occurred at the junction between the A2 and A3 states. The intensity and 
duration of these coherence clusters did not show significant differences among 4 groups of rats. 
During the bradycardia period (A3), EEG signals showed intense coherent activity at lower 
frequency ranges (5-55 Hz) with varying duration and intensity. In rats injected with saline and 
phentolamine, CCoh was intense and continuous. However, in rats injected with atenolol and 
phentolamine plus atenolol, CCoh was weaker and intermittent. 
 
Figure 2.2 Adrenergic blockade prolongs cortical coherence (CCoh) duration. (A) CCoh (averaged over 
six EEG channels) before (50 sec) and after asphyxia in four groups of rats: (a) saline, (b) phentolamine, 
(c) atenolol, and (d) phentolamine plus atenolol. x axis shows time, y axis shows frequency, and z axis 
shows CCoh. Warmer color represents stronger CCoh. Asphyxia was induced at time 0 sec. (B) The mean 
and SD of CCoh duration after asphyxia in four groups of rats: S (saline, n = 10), P (phentolamine, n = 7), 
A (atenolol, n = 8), and P+A (phentolamine plus atenolol, n = 11). Significant differences of CCoh 
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duration among 4 groups of rats are indicated using asterisks. Error bars denote SD (*p < 0.05, **p < 
0.01, ***p < 0.001). 
To investigate the effects of adrenergic blockade on the length of functional activities of 
the brain, we compared the duration of CCoh in four groups of rats (Figure 2.2B): saline (314 ± 
45 sec), phentolamine (394 ± 61 sec), atenolol (492 ± 86 sec), and phentolamine plus atenolol 
(608 ± 127 sec). We found significant increase in the duration of CCoh in all three drug groups 
from the saline treatment. Remarkably, rats received phentolamine plus atenolol had the most 
significant increase in the duration of CCoh (p < 0.001). 
2.3.3 Adrenergic blockade abolishes cardiac event related potentials and cortical coherence 
during A3 specifically in the right hemisphere 
To define the impact of the adrenergic drugs on local neuronal synchrony within the cortex, we 
analyzed cardiac event related potentials (CERP) [Li et al., 2015a] (Figure 2.3). EEG potentials 
(CERP) associated with ECG signals were seen in all rats during A3 phase of asphyxia, although 
they were undetectable in baseline or at early phase of asphyxia. CERP appeared evenly 
distributed among the 6 EEG electrodes in the saline treated rats, with slightly higher potential in 
the occipital lobes compared to the frontal lobes (Figure 2.3Aa). In the rat treated with both 
phentolamine and atenolol (Figure 2.3Ba), however, CERP was severely suppressed in all three 
electrodes specifically in the right hemisphere. This data demonstrates that adrenergic signaling 
underlies the CERP and its impact is dominant in the right cerebral hemisphere.  
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Figure 2.3 Adrenergic blockade leads to a marked hemispheric asymmetry of cardiac event related potential (CERP) and cortical coherence 
(CCoh). Raw ECG and EEG data (200-205 sec in A3), as well as CCoh raw data (50 sec before and 800 sec after asphyxia), for each hemispheric 
channel or channel-pair among the six EEG channels, is shown for one representative control rat (A) and a rat received phentolamine plus atenolol 
(B). The blockers inhibit cardiac event related EEG potentials (Ba) and CCoh (Bb) specifically on the right hemisphere and the effects are more 
significant when phentolamine plus atenolol were used together (C). Significant differences of mean pairs of CCoh, calculated for A3 at 5-55 Hz, 
are indicated using asterisks in panel C. LF: left frontal; RF: right frontal; LP: left parietal; RP: right parietal; LO: left occipital; RO: right 
occipital. Error bars denote SD (*p < 0.05, ***p < 0.001)
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We also separated the coherence pairs formed between electrodes on the left hemisphere 
from those on the right hemisphere for both control and drug injected rats. Cortical coherence 
(CCoh) on the left cortex and the right cortex showed similar levels during A3 period (the white 
dashed boxes in Figure 2.3Ab) in a control rat. In a marked contrast, the CCoh on the right 
hemisphere was nearly abolished by the injected adrenergic blockers (Figure 2.3Bb). The drug-
induced hemispheric asymmetry of CCoh during A3 was significant for rats when either atenolol 
or atenolol and phentolamine was used (Figure 2.3C). Importantly, when both phentolamine and 
atenolol were used together, the left and right asymmetry was more significant, compared to 
when either drug was used alone (Figure 2.3C). This data indicates that the drugs that do not 
penetrate the blood-brain-barrier can exert a major impact on the functional connectivity within 
the cerebral cortex during asphyxic cardiac arrest. 
2.3.4 Brain functional connectivity parallels with cardiac electrical activity 
Adrenergic blockade significantly prolonged both cardiac activity (Figure 2.1) and functional 
cortical connectivity (Figure 2.2) and longer survival was observed when both beta1- and alpha-
adrenergic receptors were simultaneously inhibited. When ECG duration was compared with 
CCoh duration (Figure 2.4), a significance correlation between CCoh duration and ECG duration 
was found for each group of rats (saline: r2 = 0.974, p < 0.001; phentolalamine: r2 = 0.969, p < 
0.001; atenolol: r2 = 0.731, p < 0.05; phentolamine plus atenolol: r2 = 0.878, p < 0.01). A 
significant correlation was found between CCoh duration and ECG duration (r2 = 0.983, p < 
0.001). Thus, the longer the brain was functioning, the longer the heart was signaling, despite a 
continued lack of oxygen supplies.    
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Figure 2.4 Cardiac survival parallels with cortical coherence (CCoh) duration. Each circle represents data 
from one rat. Linear regression line was plotted to show the correlation between ECG signal duration and 
CCoh duration for all four groups of rats. Significant correlations between ECG signal duration and CCoh 
duration are indicated using asterisks. Different color circles represent different treatment groups: saline 
control in black, phentolamine in green, atenolol in red and phentolamine plus atenolol in blue.  The 
magenta color represents values obtained with all four groups of rats (n = 35). (*p < 0.05, **p < 0.01, 
***p < 0.001). 
2.3.5 Adrenergic blockade suppresses the initial heart-rate reduction induced by asphyxia 
In Figure 2.1A, we noticed that during A1 and A2, the transient lengthening of RRI (i.e., 
reduction of heartrate) was less obvious in rats received atenolol and phentolamine plus atenolol 
than saline and phentolamine. To quantify these changes, we compared the initial rise of RRI in 
4 groups of rats (Figure 2.5). Baseline RRI (RRI-CO2) was obtained by averaging the RRI for 100 
sec-long ECG data before asphyxia induction. RRI after asphyxia (RRI+CO2) was defined by the 
first peak value of RRI after asphyxia. The RRI changes were expressed as percent changes of 
RRI after asphyxia versus baseline (RRI+CO2*100/RRI-CO2). We found that the initial increase of 
RRI was significantly suppressed by each drug (panel Ab), and that rats received both 
phentolamine and atenolol had the most significant suppression for RRI. When the extent of the 
RRI changes was compared with drug-dependent changes of ECG duration (Figure 2.5Ba) and 
CCoh duration (Figure 2.5Bb), significant correlations were found between RRI changes and 
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ECG duration (r2 = -0.689, p < 0.01), and between RRI changes and CCoh duration (r2 = -0.747, 
p < 0.01). These data demonstrate that a larger initial RRI expansion (thus a larger reduction of 
heart rate) was significantly associated with a shorter ECG duration and a shorter period of brain 
function.   
 
Figure 2.5 Adrenergic blockade suppresses the initial rise of RR interval (RRI), which negatively 
correlates with cardiac survival and cortical coherence (CCoh) duration. (A) Electrocardiomatrix (ECM) 
display of ECG signals -15 sec before and 30 sec after asphyxia for one control rat (panel a). RRI-CO2 
represents the averaged baseline RRI (100 sec before asphyxia); RRI+CO2 indicates the peak amplitude of 
the first increase of RRI after asphyxia. The mean and SD of RRI change (RRI+CO2×100/RRI-CO2) shows 
drug-specific changes (panel b). Significant differences of RRI among the rats are indicated using 
asterisks. Error bars denote SD (*p < 0.05, **p < 0.01, ***p < 0.001). (B) RRI changes are correlated 
with the survival times of both the heart (panel a) and the brain (panel b). Each circle represents data from 
one rat. Linear regression lines were plotted to show the correlation between RRI change and ECG 
duration (panel a), and between RRI change and CCoh duration (panel b) for all four groups of rats. 
Significant correlations between RRI change and ECG duration, or between RRI change and CCoh 
duration are indicated using asterisks (*p < 0.05, **p < 0.01, ***p < 0.001). 
38 
 
2.3.6 Adrenergic blockers suppress brain-heart communication 
To explore the effects of adrenergic blockade on functional coupling between the brain and 
heart, we examined corticocardiac coherence (CCCoh) before and after asphyxia for all four 
groups of rats (Figure 2.6), a method developed in our previous study [Li et al., 2015a]. CCCoh 
was not detectable before asphyxia and during stages A1 and A2 in any of the rats. During 
bradycardia phase (A3), strong CCCoh at lower frequency (5-55 Hz) emerged with a delay, 
surged to its peak within 2 minutes of asphyxia, and persisted for as long as the ECG signal was 
detectable (Figure 2.6A). Similar to the CCoh examined earlier (Figure 2.2), CCCoh displayed 
different durations and distinct patterns among the different drug groups. In rats injected with 
saline and phentolamine, the duration of CCCoh was short, but the CCCoh was strong and 
continuous. However, in rats injected with atenolol and phentolamine plus atenolol, the duration 
of CCCoh was longer, but the CCCoh was weaker and intermittent.     
To quantify the effects of adrenergic blockade on the functional coupling between the 
brain and the heart after asphyxia, we compared the mean intensity of CCCoh in four groups of 
rats (Figure 2.6B): saline (0.52 ± 0.068), phentolamine (0.55 ± 0.075), atenolol (0.38 ± 0.095), 
and phentolamine plus atenolol (0.41 ± 0.063). Since only a few of the rats treated with atenolol 
or atenolol with phentolamine exhibited ventricular tachycardia/fibrillation at the end of their 
lives (Table 1), we focused on the A3 period in all subsequent analysis. We found that the mean 
CCCoh levels was significantly lower in rats received either atenolol or phentolamine plus 
atenolol than saline or phentolamine alone. This data suggests that beta-adrenergic signaling 
plays a major role in mediating the brain and heart functional connectivity during asphyxic 
cardiac arrest. Interestingly, drug-dependent suppression of CCCoh was significantly higher on 
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the right hemisphere, compared to the left when rats received both alpha and beta-blockers 
(Figure 2.6C).    
 
Figure 2.6 Adrenergic blockade decreases corticocardiac coherence (CCCoh). (A) CCCoh (averaged over 
all channel pairs) before (50 sec) and after asphyxia in four groups of rats: (a) saline, (b) phentolamine, 
(c) atenolol, and (d) phentolamine and atenolol. (B) The mean and SD of mean CCCoh (5-55Hz) after 
asphyxia in four groups of rats. (C) Impact of drugs on hemispheric asymmetry of CCCoh in four groups 
of rats. Significant differences of mean CCCoh among 4 groups of rats (B) or between the left and right 
side of the brain (C) are indicated using asterisks. Error bars denote SD (*p < 0.05, **p < 0.01, ***p < 
0.001). 
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2.3.7 Adrenergic blockade results in marked asymmetry and regional specificity of heart-
brain coupling 
To further investigate the impact of adrenergic blockers on electrical coupling of the heart with 
the 6 different regions of the cortex, we examined the coherence between ECG signals and each 
of the six cortical signals (Figure 2.7). In rats received saline (panel Aa), CCCoh appeared 
equally strong at all brain sites and there were no apparent differences between the six cortical 
regions. In contrast, however, in rats received both phentolamine and atenolol (panel Ab), the 
right side of the cortex displayed marked reduction of CCCoh compared with the left side. 
Furthermore, there appeared to be a front-to-back gradient of CCCoh within the cortex, with 
frontal lobes exhibiting much weaker coupling with the heart than the occipital lobes (Figure 
2.7A). 
We quantified the differences in CCCoh among six cortical channels for each of the four 
groups of rats in A3 phase (Figure 2.7B). In general, the left side of the cortex appeared to have a 
stronger coupling with the heart than the right side of the brain, and the frontal lobes displaying 
lower coupling with the heart than the parietal and occipital lobes. In control rats, the CCCoh in 
occipital lobes was significantly higher than ipsilateral frontal lobes on both left and right 
hemispheres. In rats received atenolol, left frontal lobe shows higher CCCoh than the right 
frontal lobe, which shows lower CCCoh than both the parietal and occipital lobes of the same 
side. Remarkably, in rats received both phentolamine and atenolol, the CCCoh on the right side 
of the brain was significantly weaker than the left side of the brain, and the frontal lobe was 
significantly lower than parietal lobe, which was significantly lower than the occipital lobe. We 
also compared the CCCoh at each locus between the 4 groups of rats (Figure 2.7C). Significant 
differences on the left hemisphere between drug groups were identified only between rats treated 
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with phentolamine and atenolol. This effect appears to result from a slight increase of CCCoh by 
phentolamine and slight decrease by atenolol, though none of the drug treated groups had 
significant difference when compared with the control group (upper panels in Figure 2.7C). On 
the right hemisphere (lower panels in Figure 2.7C), however, beta-blockade significantly 
suppressed CCCoh compared to both control as well as alpha blocker-treated rats. The group 
treated with both alpha and beta blockers showed identical results with those treated with beta 
blocker alone, suggesting that alpha blocker had no effect for brain-heart coherence on the right 
hemisphere.  Thus beta-blocker suppresses brain-heart coherence specifically and significantly 
on the right hemisphere of the brain.  
 
Figure 2.7 Adrenergic blockade leads to asymmetric corticocardiac coherence (CCCoh). (A) CCCoh raw 
data for each of the six EEG channels before (50 sec) and after asphyxia is shown for one representative 
control rat (panel a) and a rat received phentolamine plus atenolol (panel b). LF: left frontal; RF: right 
frontal; LP: left parietal; RP: right parietal; LO: left occipital; RO: right occipital. (B) CCCoh displays 
hemispheric asymmetry in rats treated with drugs. The mean and SD of CCCoh (5-55Hz) after asphyxia 
for each of the six EEG channels in four groups of rats. (C) Beta blocker inhibits CCCoh specifically on 
the right hemisphere. Significant differences of mean CCCoh among 6 EEG channels are indicated using 
asterisks in both panels B and C. Error bars denote SD (*p < 0.05, **p < 0.01, ***p < 0.001). 
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2.3.8 Beta blocker suppresses bi-directional effective communications between the brain 
and the heart 
To explore the impact of adrenergic blockade on bi-directional brain-heart information transfer, 
we examined effective connectivity between the brain and heart (CCCon) in the four groups of 
rats (Figure 2.8). In all rats (panels Aa-Ad), connectivity remained at baseline levels during 
stages A1 and A2, the early phase of asphyxia. During bradycardia (A3), there was a delayed 
surge of connectivity in both afferent (feedforward or FF, from the heart to the brain) and 
efferent (feedback or FB, from the brain to the heart) directions, with efferent connectivity 
dominated in all rats (Figure 2.8A).   
To quantify the effects of adrenergic blockade on directional information transfer 
between the brain and the heart following asphyxia, we examined brain-heart effective 
connectivity in both directions (Figure 2.8B). The mean CCCon was calculated in four groups of 
rats in both directions: saline (FF: 0.0159 ± 0.0020; FB: 0.0215 ± 0.0078), phentolamine (FF: 
0.0148 ± 0.0017; FB: 0.0250 ± 0.0057), atenolol (FF: 0.0083 ± 0.0009; FB: 0.0101 ± 0.0029), 
and phentolamine plus atenolol (FF: 0.0090 ± 0.0012; FB: 0.0121 ± 0.0025). We found that the 
mean CCCon in both directions was significantly lower in rats received atenolol or both 
phentolamine plus atenolol than saline or phentolamine alone, indicating that blockade of beta-
adrenergic signaling significantly decreased the brain and heart bi-directional information 
transfer during asphyxic cardiac arrest. Furthermore, phentolamine, when combined with 
atenolol, increased the efferent connectivity, but had no impact on the afferent connectivity, 
compared with atenolol alone where there was no feedback dominance of the brain-heart 
connectivity. Further analysis identified the impact of adrenergic drugs on the hemispheric 
asymmetry of brain-heart connectivity (Figure 2.8C): In rats treated with atenolol, afferent 
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connectivity (FF-CCCon) is stronger on the left side than on the right side, while in rats treated 
with phentolamine and phentolamine plus atenolol, efferent connectivity (FB-CCCon) on the 
right side of the brain is significantly suppressed than on the left side. Moreover, efferent 
connectivity was significantly stronger than afferent connectivity for control rats as well as rats 
injected with phentolamine or phentolamine plus atenolol and this effect is significant only on 
the left hemisphere. The alpha blocker elevated the efferent connectivity specifically on the left 
hemisphere when injected together with atenolol.   
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Figure 2.8 Adrenergic blockade decreases corticocardiac directional connectivity (CCCon). (A) CCCon, 
measured by the Normalized Symbolic Transfer Entropy (NSTE), shows high levels of feedback (from 
the brain to the heart or efferent) connectivity directed from the brain to the heart in 4 representative rats. 
CCCon (averaged over six EEG channels) before (50 sec) and after asphyxia in four representative rats: 
(a) saline, (b) phentolamine, (c) atenolol, and (d) phentolamine and atenolol. Red trace shows feedforward 
(from the brain to the heart) CCCon and blue trace shows feedback (from the heart to the brain) CCCon. 
(B) The mean and SD of CCCon (5-55Hz) during A3 phase (see panel A) in four groups of rats. Solid 
bars represent afferent CCCon and patterned bars represent efferent CCCon. Significant differences of 
afferent CCCon among 4 groups of rats are indicated using blue asterisks, and that of efferent CCCon 
among 4 groups are indicated using red asterisks. (C) Left and right asymmetry of afferent and efferent 
brain-heart connection in different drug groups. Significant differences between afferent and efferent 
CCCon are marked by pound signs. Error bars denote SD (*/#p < 0.05, **/##p < 0.01, ***p < 0.001). 
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2.3.9 Adrenergic blockade leads to marked hemispheric asymmetry and regional specificity 
of heart-brain effective connectivity 
To investigate if adrenergic blockers affected brain-heart directional information transfer equally 
at the left and right, and at the front and back of the brain, we examined the effective 
connectivity between the heart and each of the six cortical loci (Figure 2.9). In rats received 
saline, the connectivity with the heart appeared slightly lower on the right side than the left side 
of the brain (panel Aa). However, in rats received both phentolamine and atenolol, the 
connectivity on the right side of the cortex was markedly reduced (panel Ab). Moreover, the 
connectivity in the frontal lobe appeared lower compared to the parietal and occipital lobes. In 
both rats, efferent connectivity (red tracings) appeared stronger than afferent connectivity (blue 
tracings).  
Examination of the differences of brain-heart connectivity among six cortical channels 
for all four groups of rats revealed that the connectivity was affected by the drugs differentially 
at left and right side, and at the frontal and occipital regions of the brain (Figure 2.9B). Within 
each drug group and at each cortical location, connectivity is higher in the efferent direction from 
the left hemisphere than in the afferent direction, except the atenolol group. There was no 
directional asymmetry on the right hemisphere at any of the three cortical loci and within any of 
the 4 groups. Interestingly, no directional asymmetry was found in rats injected with atenolol at 
any of the 6 cortical regions. These data suggest that efferent signaling to the heart is more robust 
than afferent communication during asphyxia. Robust and significant efferent dominance over 
afferent connection was found at left frontal, left parietal, and left occipital lobes in saline, 
phentolamine, and phentolamine/atenolol treated rats (p < 0.05). In addition, all 4 groups of rats 
exhibited higher levels of afferent connectivity at occipital lobes than at the frontal lobes. In rats 
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treated with both phentolamine and atenolol, both afferent (p < 0.05) and efferent (p < 0.01) 
brain-heart connectivity was suppressed on the right side of the brain. 
 
Figure 2.9 Adrenergic blockade affects corticocardiac connectivity (CCCon) with left and right 
hemispheric asymmetry, directional asymmetry, and regional specificity. (A) CCCon for each of the six 
EEG channels before (50 sec) and after asphyxia in one representative control rat (panel a) and a rat 
received phentolamine plus atenolol (panel b). Red trace shows afferent CCCon and blue trace shows 
efferent CCCon. (B) Regional differences on the effect of drugs on CCCon within each drug group. (C) 
Impact of drugs on hemispheric asymmetry, directional asymmetry, and regional specificity of CCCon 
compared between different drug groups. Solid bars represent afferent CCCon and patterned bars 
represent efferent CCCon. Significant differences in afferent CCCon among 4 groups of rats are indicated 
using blue asterisks, while that of efferent CCCon are indicated by the red asterisks. Significant 
differences between FF and FB CCCon are marked by pound signs. Error bars denote SD (*/#p < 0.05, 
**/##p < 0.01, ***p < 0.001). 
The adrenergic blockers resulted in directional asymmetry (afferent vs. efferent), 
hemispheric asymmetry (left vs. right), and regional specificity (frontal vs. parietal vs. occipital) 
of brain-heart connectivity in the dying rats; and the effect was drug-specific. In each of the 6 
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cortical locations, atenolol significantly reduced the afferent brain-heart connectivity on both left 
(p < 0.01) and right (p < 0.001) hemisphere (panel Ca). Phentolamine had no effects on afferent 
connectivity to any of the 6 cortical loci. In addition, atenolol significantly suppressed efferent 
brain-heart connectivity in all 6 cortical regions (p < 0.01), while phentolamine displayed no 
significant impact on efferent connectivity on either hemisphere by itself (panel Cb). In rats 
treated with both atenolol and phentolamine, however, the efferent connectivity was significantly 
higher in rats treated with both alpha- and beta-blockers than in rats treated with the beta-blocker 
alone. Importantly this effect of phentolamine on brain-heart connectivity was limited to the 
efferent direction and exclusive to the left hemisphere (panel Cb).  
2.3.10 Summary of the findings 
Our data demonstrate that (1) simultaneous blockade of alpha- and beta-adrenergic signaling 
extends durations of both cardiac and cortical functional electrical activities and (2) beta-blocker 
suppresses bi-directional electrical communications between the heart and all regions of the 
cerebral cortex during asphyxic cardiac arrest. More specifically, beta blocker (1) nearly 
eliminated the occurrence of ventricular tachycardia and ventricular fibrillation induced by 
asphyxia, (2) significantly (p < 0.01) suppressed the initial and rapid decline of heart rate, (3) 
reduced the brain-heart coherence, significantly (p < 0.01) only on the right hemisphere, and (4) 
blocked both the efferent/feedback (brain-heart; p < 0.01) and afferent/feedforward (heart-brain; 
p < 0.001) signaling. Alpha blocker, on the other hand, (1) reduced the initial decline of heart 
rate (p < 0.01), (2) prolonged the duration of both cardiac (p < 0.05) and cortical (p < 0.05) 
functional electrical activities, and (3) when used in combination with beta blocker, reversed beta 
blocker-mediated significant suppression of efferent/feedback signaling significantly only on the 
left hemisphere. Importantly, when both alpha- and beta-adrenergic receptors were 
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simultaneously suppressed, ECG duration as well as cortical coherence duration were both 
lengthened and the combined drug effects were significantly higher than either drug used alone. 
Furthermore, the combined blockade of alpha and beta-receptors markedly suppressed cortical 
coherence, specifically on the right hemisphere. 
 
Figure 2.10 Adrenergic blockers bi-directionally and asymmetrically affect functional brain-heart 
communication. (A) Beta-adrenergic blockade markedly suppresses functional corticocardiac coherence 
(CCCoh) on the right hemisphere. (B) Beta-adrenergic blockade significantly suppresses both the afferent 
and efferent corticocardiac connectivity (CCCon), especially on the right hemisphere. Alpha-adrenergic 
blockade increases the efferent CCCon on the left hemisphere in the presence of atenolol. [--: decrease, p 
< 0.01; ---: decrease, p < 0.001; (+): significant increase only when atenolol was present; L: left; R: right]. 
The colored curved arrows indicate the direction of brain-heart communication. 
The key findings on corticocardiac connectivity are illustrated in Figure 2.10. The beta 
blocker atenolol markedly suppressed brain-heart communications in asphyxic rats, by reducing 
the functional corticocardiac coherence (panel A) and effective corticocardiac connectivity 
(panel B). It is worth to note that atenolol’s inhibitory actions on the brain-heart loop are 
significantly stronger on the right hemisphere for both coherence (panel A) and connectivity 
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(panel B) measures and that atenolol markedly suppresses both afferent (left panel in B) and 
efferent (right panel in B) communications between the cortex and the heart. Alpha blocker 
phentolamine, on the other hand, had no significant effect by itself for brain-heart 
communication. However, when used together with atenolol, phentolamine reversed the 
suppressive effects of atenolol on brain-heart connectivity. Importantly, this effect was limited to 
efferent signaling and unique to the left hemisphere (right panel in B). Taken together, these data 
suggest that beta blocker exerts its beneficial effects by reducing both afferent (feedforward) and 
efferent (feedback) communications with stronger impact on the right hemisphere.    
2.4 Discussion 
In this manuscript, we examined the impact of sympathetic blockers on the functional activities 
of the heart and the brain and functional interaction between the two vital organs in rats during 
asphyxic cardiac arrest. The results support our hypothesis [Li et al., 2015a] that the rapid 
cardiac demise by asphyxia stems from the sympathetic insult actively imposed by aroused brain.   
2.4.1 Role of the brain during asphyxic cardiac arrest 
Currently, very few studies have focused on the impact of the brain on the heart during cardiac 
arrest. We have shown that the brain is immediately aroused when rats are exposed to CO2 [(Li 
et al., 2015a]; this study]. The brain activation, reflected by increased cortical coherence at high 
gamma and theta waves, was associated with an increased RRI (decreased heart rate) and a 
subsequent brief recovery of RRI within the first minute. Interestingly, there was no detectable 
electrical communication between the heart and the cortex during this period. A further increase 
of RRI was followed by a marked surge of brain-heart coherence and connectivity that lasted for 
the entire duration of ECG signals. These data lead to the following hypotheses: (1) asphyxia-
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stimulated cortical signaling promotes autonomic activation during early phase of cardiac arrest 
via a homeostatic survival circuit, and the events in this early phase is likely mediated by 
subcortical players; (2) when the early rescue efforts fail, the brain mounts an intensive and 
sustained sympathetic activation, as reflected by the marked surge of corticocardiac coherence 
and bi-directional corticocardiac connectivity at later phase of cardiac arrest. The fact that 
adrenergic blockers suppressed the expansion of RRI during the early phase (Figure 2.5) 
supports the hypothesis #1 above. The data demonstrating reduced cortex-heart communication 
by beta-blocker atenolol during the later phase (Figures 2.7 and 2.9) supports the hypothesis #2. 
These data suggest that the rapid death by asphyxia is mediated by the overstimulation of the 
sympathetic system of the brain.          
2.4.2 Animal models for cardiac arrest 
Cardiac arrest kills more than 300,000 Americans each year and < 5% of out-of-hospital victims 
of cardiac arrest survive [Nolan et al., 2012]. Initial triggers that lead to cardiac arrest include 
sudden failures of cardiovascular, neurological, and pulmonary functions, accidents (drowning, 
choking, automobile accidents, etc), or drug overdose [Israel, 2014]. Most, if not all, of these 
sudden death occur in the absence of anesthesia. Of the various animal models used for cardiac 
arrest studies (intra-cardiac injection of toxins, electrical fibrillations, trachea occlusion, and non-
oxygen gases induced asphyxiation), however, very few could be performed ethically in the 
absence of anesthesia. This issue is important, as anesthesia is well known to induce marked 
changes in autonomic functions [Farber et al., 1995] and can confound the interpretation of 
studies. Unlike other animal models, CO2-mediated asphyxic cardiac arrest can be conducted 
easily in the absence of anesthesia and has been widely used to euthanize small laboratory 
rodents. This model has been used successfully to investigate brain-heart interactions during 
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asphyxia [Borovsky et al., 1998; Borjigin et al., 2013; Li et al., 2015a] and was the model of 
choice for our investigation of brain-heart communications in the present work. In future studies, 
non-oxygen gases, such as nitrogen [Borovsky et al., 1998], can be tested side-by-side with CO2 
to examine the impact of hypercapnea on brain-heart coupling. We also plan to monitor 
additional physiological parameters, such as blood pressure, pulse, and sympathetic nerve 
activity, in animal models of cardiac arrest.    
2.4.3 Sympathetic toxicity and sudden death 
Sudden death is associated with elevated sympathetic activities [Samuels, 2007; Sörös and 
Hachinski, 2012; Israel, 2014]. Elevated efferent sympathetic activity, measured by increased 
release of plasma norepinephrine, was detected in patients with sleep apnea [Baylor et al., 1995], 
myocardial damage [Mueller and Ayres, 1980], sustained ventricular arrhythmias [Meredith et 
al., 1991], and in rats dying from CO2 inhalation [Borovsky et al., 1998]. Beta blockers reduce 
incidence of sudden cardiac death, cardiovascular death, and all-cause mortality [Yusuf et al., 
1985; Al-Gobari et al., 2013]. Atenolol, a blocker of beta-adrenoceptor that does not pass 
through the blood-brain barrier, is used in human patients to treat a number of conditions 
including hypertension, angina, acute myocardial infarction, supraventricular tachycardia, and 
ventricular tachycardia [Patterson and Lucchesi, 1984; Draper et al., 1992]. Mechanisms for the 
beneficial effects of beta-blockers including atenolol, however, remain unclear [Yusuf et al., 
1985; Bourque et al., 2007].  
 CO2 results in cardiac arrest in less than five minutes [Coenen et al., 1995; Li et al., 
2015a]. When the efferent neuronal signaling was blocked by cord transection, however, the 
duration of ECG and EEG signals was extended to more than 15 minutes in asphyxic rats, 
despite the continued absence of oxygen; and this effect was independent of atropine [Li et al., 
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2015a]. This data suggests that the blockade of sympathetic action may be beneficial for 
prolonging the survival of both heart and brain in dying individuals, an idea tested in a rat model 
in the present work. Elevated sympathetic activity was reported in rats dying from CO2-mediated 
asphyxiation [Borovsky et al., 1998]. Importantly the effect of CO2 on norepinephrine release 
was shown to result from hypoxic rather than hypercapnic action of the gas and is independent of 
adrenally released epinephrine [Borovsky et al., 1998]. In our studies [Li et al., 2015a; this 
study], asphyxia induced a delayed surge of corticocardiac coherence and bi-directional 
connectivity between the brain and the heart. Atenolol, administered prior to asphyxia, 
significantly suppressed the brain-heart communication (Figures 2.7-2.9). In fact, the beta-
blocker inhibits both efferent signaling from the brain to the heart and afferent signaling from the 
heart to the brain and extended the functional activity of both vital organs. In support of our 
finding, beta-blockers were shown to lower norepinephrine release in human subjects [Mueller 
and Ayres, 1980; Vincent et al., 1984; Packer, 1998] and rats [Berg, 2014]. Thus peripherally 
acting beta-blocker alters the feedback/efferent effective corticocardiac connectivity by 
inhibition of norepinephrine release at the presynaptic beta1-adrenoceptors [Berg, 2014]. These 
data indicate that the cerebral cortex is an essential part of a survival feedback loop and support 
the notion that sympathetic storm stimulated by a sudden drop of cardiovascular functions is the 
root cause of most, if not all, sudden cardiac arrest cases.  
2.4.4 Cerebral asymmetry in autonomic control of the heart 
Brain control of cardiac activity is lateralized, with left hemisphere associated with 
parasympathetic and right hemisphere with sympathetic functions [Wittling et al., 1998a; 
Wittling et al., 1998b; Critchley et al., 2005; Foster and Harrison, 2006]. Consistent with the 
right hemisphere predominance in sympathetically mediated cardiac control [Wittling, 1998b], 
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the beta-blocker specifically and significantly inhibited cortical coherence (Figure 2.3; in 
combination with phentolamine) and corticocardiac coherence (Figures 2.6 and 2.7) only on the 
right cerebral loci and inhibition of feedforward (afferent) corticocardiac directed connectivity 
by atenolol was more significant on the right hemisphere (p < 0.001) than the left hemisphere (p 
< 0.01) (Figure 2.9C). Interestingly, atenolol’s suppressive effect on brain-heart coupling was not 
limited to the right hemisphere (Figure 2.9C); a significant (p < 0.01) inhibition of bi-directional 
effective brain-heart connectivity was detected on the left cortex. This data suggests that 
blockade of peripheral beta1-adrenergic receptors leads to downregulation of central sympathetic 
as well as parasympathetic signaling. These data are consistent with known mechanisms of 
autonomic regulation of the heart [Wehrwein et al., 2016]. Furthermore, they support the validity 
of our new approach for pharmacological dissection of signaling mechanisms within the cardiac 
survival circuit, to which the cerebral cortex is an essential player.      
2.4.5 Dual alpha and beta blockers for lengthening the functional brain and heart activity 
The two branches of the autonomic nervous system regulate cardiac functions through 
norepinephrine released by the sympathetic nerves and acetylcholine secreted by the vagal 
nerves. An extensive and reciprocal interaction, reflected by a prejunctional cholinergic 
modulation of adrenergic [Vanhoutte and Levy, 1980] and prejunctional adrenergic modulation 
of cholinergic [Akiyama and Yamazaki, 2000] neurotransmissions, exists between the two 
systems [Vizi, 1974; Vanhoutte and Levy, 1980; Wehrwein et al., 2016]. Specifically, 
norepinephrine, acting on the presynaptic adrenergic receptors inhibits acetylcholine release on 
postganglionic vagal nerve terminals, and this effect is abolished with phentolamine [Akiyama 
and Yamazaki, 2000]. In the present study, phentolamine, when used together with atenolol, had 
significantly more beneficial effects in prolonging functional activities of the brain and heart 
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than either drug alone (Figures 2.1 and 2.2). The dual blockers significantly (p < 0.001) 
increased the duration of functional activities of both the brain and the heart, and suppressed the 
initial expansion of RRI. Interestingly, the effect of the alpha blocker on brain-heart coupling 
was limited to the left cerebral hemisphere, in contrast to the right dominance of atenolol’s 
effect. Furthermore, phentolamine’s effect was more significant when both drugs were used 
together (Figures 2.3B, 2.3C, 2.6C, 2.7B, and 2.9B), and phentolamine significantly reversed the 
suppressive effect of atenolol on efferent corticocardiac connectivity, specifically on the left 
hemisphere (Figure 2.9Cb). These data suggest that phentolamine acts on the prejunctional alpha 
adrenoceptors to elevate the release of acetylcholine from cholinergic terminals in the 
myocardium, when beta1-adrenoceptors are blocked by atenolol.  
2.4.6 Peripheral sympathetic blockade alters cortical and corticocardiac connectivity  
Drugs used in this study, atenolol and phentolamine, are well known to affect cardiac functions. 
Consistent with their roles in the heart, the blockers (1) suppressed occurrence of VT/VF (Table 
1 and Supplement Figure 1 in Appendix), (2) suppressed the initial drop of heart rate (Figure 
2.5Ab), and (3) extended cardiac survival time (or the ECG duration; Figure 2.1B). More 
importantly, although having a minimum blood-brain barrier penetration [Neil-Dwyer et al., 
1981; Nordling et al., 1981], they exerted marked impact on the dynamics of cortical functional 
connectivity (Figure 2.3) and corticocardiac coupling (Figures 2.6-2.9). We believe that this 
effect is due to the existence of a powerful corticocardiac loop (CCL), an extension of the 
autonomic nervous system that connects the heart with the cerebral cortex. Changes at either end 
of the CCL, in the heart or the cortex, can functionally influence the outcome at the other end. 
Thus, emotional trauma, a largely cerebral event, can precipitate a sudden arrest of the heart 
[Kassim et al., 2008; Sharkey et al., 2011], possibly via the efferent branch of this interconnected 
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CCL. Our data in this study provide evidence for the existence of the afferent branch of the 
CCL: blocking adrenergic receptors of the heart with drugs that do not penetrate the blood-brain 
barrier can powerfully alter the functional dynamics of cortical and corticocardiac connectivity. 
Further investigation of this intriguing loop may help elucidate (1) the role of the brain in cardiac 
diseases and (2) the impact of cardiac events on brain function. It should be noted that our 
finding that the functional connectivity within the brain and between the brain and heart is 
pharmacologically sensitive and hemispherically asymmetric alleviates the concern that ECG 
signals were artifactually detected in cortical electrodes. 
2.4.7 A new tool for non-invasive investigation of brain-heart communications 
Functional communications within the brain between two or more neuronal networks have been 
studied successfully using coherence [Sakkalis, 2011; Fries, 2015; Harris and Gordon, 2015] and 
connectivity metrics [Lee et al., 2009; Lee et al., 2015; Li et al., 2015a]. Similar methods have 
been developed for analysis of electrical signals encoding different forms of information.  
Coherence between EMG and EEG signals, for instance, has been analyzed as a measure for 
neural control of locomotion [Enders and Nigg, 2016]. We have pioneered the use of functional 
and effective connectivity measures to investigate neural control of cardiovascular functions [Li 
et al., 2015a]. Using this method, we have analyzed coherence and connectivity between heart 
and brain electrical signals and successfully demonstrated a surprisingly tight electrical 
communication between the heart and the cortex in dying rats [Li et al., 2015a]. While this mode 
of communication was undetected in healthy rats from the 6 cortical loci, it should be detectable 
in normal individuals when EEG electrodes are placed directly within brain regions with known 
involvement in the autonomic control of cardiac functions such as insular cortex, paraventricular 
nucleus, etc. Our ongoing research in human patients also identified a surge of corticocardiac 
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coherence and connectivity when their cardiac functions failed suddenly (manuscript in 
preparation). In the present manuscript, we have further expanded the utility of this novel 
approach to probing the signaling mechanisms of bi-directional brain-heart communication. We 
plan to apply this approach extensively in future studies to probe the mechanisms of various 
cardiogenic drugs currently used in clinic.  
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Chapter 3 Corticocardiac coupling in dying human patients  
3.1 Introduction 
Sudden cardiac death remains a major public health problem, accounting for 300,000-400,000 
deaths in the United States annually [Stecker et al., 2014]. A recent North American analysis 
showed that the overall survival rate of sudden cardiac arrest was 4.6% [Nichol et al., 2008]. 
Sudden cardiac death is often the first manifestation of coronary heart disease or other structural 
heart disease, and is responsible for about 50% of the mortality from cardiovascular diseases in 
the United States and other developed countries [Myerburg and Castellanos, 2015]. However, 
sudden cardiac arrest could also be induced by non-cardiac causes, which include epilepsy, 
ischemic stroke, intracranial bleeding, traumatic heard injury, and asphyxia [Papadakis et al., 
2009; Finsterer and Wahbi, 2014]. The multi-factorial properties of sudden cardiac death make 
its prediction, prevention, and management a challenging task. Given the high incidence and low 
survival rate of sudden cardiac arrest, a better understanding on the mechanism underlying 
sudden cardiac arrest is in urgent need.  
Recent studies from our laboratory demonstrate that asphyxia induced sudden cardiac 
arrest lead to a rapid surge of functional connectivity (CCoh) and effective connectivity (CCon) 
in the dying brain [Li et al., 2015a]. In addition, asphyxia activates a surge of brain-heart 
coupling, a novel form of communication, between the brain and heart, measured by 
corticocardiac coherence (CCCoh) and directional corticocardiac connectivity (CCCon), prior to 
sudden death [Li et al., 2015a]. A dramatic release of a set of key cortical transmitters that are 
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important for the regulation of cardiovascular system is also identified during the dying process 
[Li et al., 2015a]. Based on these data, we hypothesized that the stimulated brain functions to 
resuscitate the heart during cardiac arrest, and the strong brain-heart coupling may be a potential 
biomarker to predict sudden death. However, this hypothesis has never been tested in human 
patients that suffered from sudden cardiac arrest.  
The objective of current study is to investigate the dynamic changes and functional 
interactions between the brain and the heart in patients died from cardiac arrest using the same 
signal processing approach we developed in previous studies [Brojigin et al., 2013; Li et al., 
2015a]. This study is expected to improve our understanding on how the brain and the heart 
interact during cardiac arrest in human. 
3.2 Materials and method 
3.2.1 Patient information and data collection 
This 25-year-old woman had generalized epilepsy for 1 year and long QT syndrome for 2 years. 
The patient was admitted to the intensive care unit (ICU) at the University of Michigan and was 
treated with hypothermia with long-term video, EEG (19 channels, Fpz was used as reference), 
and ECG (2 channels, lead II was used for data analysis) monitoring. The sampling frequency for 
both EEG and ECG signal was 512 Hz. Cardiac arrest was revealed to be the cause of death for 
the patient.  
3.2.2 Construction of electrocardiomatrix (ECM) and EEG matrix 
(electroencephalomatrix, EEM) 
The construction of ECM and EEM (Figure 3.1B and 3.5) begins with R-peak detection in ECG 
signal. To avoid the influence of baseline wandering, baseline drift correction was first 
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performed using second-order Butterworth high-pass filtering with a cutoff frequency of 0.5 Hz 
(butter.m and filtfilt.m in Matlab signal processing toolbox; MathWorks Inc., Natick, MA). R 
peaks of ECG signals were then detected using variable threshold method [Kew and Jeong, 
2011]. Specifically, an amplitude threshold in each nonoverlapping 1 second epoch was applied 
to select the candidates for R peaks, which can be verified only if the RRI value exceeds a 
predefined threshold. In this study, the interval threshold was selected as half of the median 
value of the RR interval (RRI) values in the last 1 second epoch. The automatically detected R 
peaks were manually validated through a custom user interface developed in Matlab 
(MathWorks Inc., Natick, MA).  
For construction of ECM [Li et al., 2015b] , a window centered on the detected R peaks 
was extracted from the ECG signal after baseline drift correction. All ECG windows were then 
sorted in the order of R-peak time and plotted as parallel colored lines to form a colored 
rectangular image. To construct EEM, a window centered on the ECG R peaks was extracted 
from the EEG signal. All EEG epochs were then sorted according to R-peak time and plotted as 
parallel colored lines. For both ECM and EEM, the intensity of signals was denoted on z axis, 
with warmer color indicating positive peaks with higher voltage, and cooler colors indicating 
lower-voltage peaks. The color scheme can be adjusted as needed. 
3.2.3 Analysis of power spectrum 
EEG power was analyzed using short time Fourier transform based on discrete Fourier transform 
with 10-second segment size and no overlapping (spectrogram.m in Matlab signal processing 
toolbox; MathWorks Inc., Natick, MA). Each segment was windowed with a Hamming window. 
The absolute power was expressed in log scale (Figure 3.2A). The averaged power for each stage 
was calculated for five frequency bands: delta (1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta 
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(13-25 Hz), and gamma (25-55 Hz). The scalp power distribution was calculated using the 
topoplot function in EEGLAB (Figure 3.2B) [Delorme and Makeig, 2004]. 
3.2.4 Analysis of CCoh and CCCoh 
To measure the CCoh among 19 EEG channels and the CCCoh between 1 ECG and each of the 
19 EEG channels, EEG and ECG signals were first segmented into non-overlapping 10-second 
epochs. For each 10-second epoch, mean coherence was calculated based on magnitude squared 
coherence estimate using Welch’s averaged periodogram method with 0.5 Hz frequency bin 
(mscohere.m in Matlab signal processing toolbox; MathWorks Inc., Natick, MA). The magnitude 
squared coherence estimate 𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) is a function of frequency with values between 0 and 1 that 
indicates how well signal x corresponds to signal y at each frequency: 
𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) = �𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓)�2𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓)𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓), 0 ≤ 𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) ≤ 1   (1) 
where 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) and 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) are the power spectral density of x and y, and 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) is the cross power 
spectral density.   
The coherence between every two EEG channels (Figure 3.3A) or between 1 EEG and 1 
ECG channel (Figure 3.6A) was plotted for frequencies from 0-55Hz. The averaged coherence 
for each studied stage was calculated at five frequency bands: delta (1-4 Hz), theta (4-8 Hz), 
alpha (8-13 Hz), beta (13-25 Hz), and gamma (25-55 Hz). The topographical distribution of 
CCoh was represented in graph, with the width of edge indicating the level of coherence (Figure 
3.3B). The scalp distribution of CCCoh was plotted using the topoplot function in EEGLAB 
(Figure 3.6B) [Delorme and Makeig, 2004]. 
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3.2.5 Analysis of CCon and CCCon 
Twelve EEG channels and 1 ECG channel were selected for connectivity calculation. The 12 
EEG channels were divided into 4 clusters: left frontal (LF: Fp1, F7, and F3), right frontal (RF: 
F8, Fp2, and F4), left posterior (LP: T5, P3, and O1), and right posterior (RP: T6, P4, and O2). 
The CCon between the 3 pairs of channels in LF and RP, as well as the 3 pairs of channels 
between RF and LP was calculated. For CCCon, the bidirectional information flow between each 
of the 12 EEG channels and ECG signal was calculated. Both CCon and CCCon were measured 
by modified [Li et al., 2015a] Normalized Symbolic Transfer Entropy (NSTE) [Lee et al., 2009], 
which is a nonlinear and model-free estimation of directional functional connection based on 
information theory. STE measures the amount of information provided by the additional 
knowledge from the past of the source signal X(𝑋𝑋𝑃𝑃) in the model describing the information 
between the past Y(𝑌𝑌𝑃𝑃) and the future Y(𝑌𝑌𝐹𝐹) of the target signal Y, which is defined as 
following: 
𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌 = 𝐼𝐼(𝑌𝑌𝐹𝐹;𝑋𝑋𝑃𝑃|𝑌𝑌𝑃𝑃) = 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) − 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑋𝑋𝑃𝑃,𝑌𝑌𝑃𝑃)   (2) 
where 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) is the entropy of the process 𝑌𝑌𝐹𝐹conditional on its past. Each vector for 
𝑌𝑌𝐹𝐹 ,𝑋𝑋𝑃𝑃 𝑎𝑎𝑎𝑎𝑎𝑎 𝑌𝑌𝑃𝑃is a symbolized vector point. The potential bias of STE was removed with a 
shuffled data, and the unbiased STE is normalized as follows:  
𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌
 = 𝑆𝑆𝑆𝑆𝑆𝑆𝑋𝑋→𝑌𝑌−𝑆𝑆𝑆𝑆𝑆𝑆𝑋𝑋→𝑌𝑌𝑆𝑆ℎ𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢 
𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌  ) ∈ [0, 1]   (3) 
where 𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌
𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑢𝑢𝑢𝑢𝑢𝑢 = 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) − 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑋𝑋𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑃𝑃 ,𝑌𝑌𝑃𝑃).   𝑋𝑋𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑃𝑃  is a shuffled data created by 
dividing the data into sections and rearranging them at random. Therefore, NSTE is normalized 
STE (dimensionless), in which the bias of STE is subtracted from the original STE and then 
divided by the entropy within the target signal, 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃). 
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For CCoh, the feedback connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝐹𝐹𝐹𝐹) was calculated over the 3 pairs of EEG 
channels from the frontal (𝑓𝑓) channels (LF/RF cluster) to the parietal (p) and occipital (o) 
channels (RP/LP cluster), which are defined as following: 
𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝐹𝐹𝐹𝐹 = 1𝑛𝑛𝑢𝑢∙𝑛𝑛𝑝𝑝,𝑜𝑜 ∑ 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑖𝑖→𝑗𝑗𝑛𝑛𝑢𝑢,𝑛𝑛𝑝𝑝,𝑜𝑜(𝑖𝑖,𝑗𝑗)=1    (4) 
where 𝑎𝑎𝑓𝑓 = 3 and 𝑎𝑎𝑝𝑝,𝑜𝑜 = 3.  The feedforward connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝐹𝐹𝐹𝐹) from the parietal and 
occipital channels (LP/RP cluster) to the frontal channels (RF/LF cluster) is vice versa.   
For CCCon, the feedback connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸) was calculated by averaging 
NSTE over 12 pairs of EEG channels to ECG channel, which are defined as follows: 
𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸 = 1𝑛𝑛𝐸𝐸𝐸𝐸𝐸𝐸 ∑ 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑖𝑖→𝑆𝑆𝐸𝐸𝐸𝐸𝑛𝑛𝐸𝐸𝐸𝐸𝐸𝐸𝑖𝑖=1    (5) 
where 𝑎𝑎𝑆𝑆𝑆𝑆𝐸𝐸 = 12. The feedforward connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝐸𝐸𝐸𝐸→𝑆𝑆𝑆𝑆𝐸𝐸) from the ECG to 12 EEG 
channels is vice versa. 
EEG and ECG signals were first filtered into five frequency bands, delta (1-4 Hz), theta 
(4-8 Hz), alpha (8-13 Hz), beta (13-25 Hz), and gamma (25-55 Hz), and then segmented into 10-
second long epochs with 5-second long overlapping. The feedback and feedforward CCon and 
CCCon were sequentially calculated for each epoch. Three parameters: embedding dimension 
(𝑎𝑎𝑆𝑆), time delay (τ), and prediction time (𝛿𝛿), are required for calculation. In this study, we 
selected the parameter setting that could yield maximum 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌  by fixing the embedding 
dimension (𝑎𝑎𝑆𝑆) at 3, and optimizing prediction time 𝛿𝛿 (from 1 to 30, corresponding to 2-60 ms 
with the sampling frequency of 512 Hz) and time delay 𝜏𝜏 (from 1 to 125, 1-250 ms). The same 
procedure was used to calculate 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑌𝑌→𝑋𝑋 , provided that the information between two signals is 
transferred through different neuronal pathways. The averaged CCon (Figure 3.4) and CCCon 
(Figure 3.7) for each stage were calculated and plotted for five frequency bands.  
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3.3 Results 
3.3.1 EEG and ECG displayed series of activity with distinct features during the dying 
process  
To explore the electrophysiological state of the brain and the heart during the dying process, raw 
EEG and ECG signals were first analyzed. Unprocessed EEG signals from 19 cortical channels 
(Figure 3.1C) and ECG data (lead II), as well as the RRI for the last hour are shown in Figure 
3.1A. According to the features of signals, six representative stages were selected for detailed 
analysis. Stage 1 (S1: 700-800 second) is characterized by normal EEG, ECG, and RRI and is 
considered as baseline. Stage 2 (S2: 2760-2890 second) is comprised of high amplitude EEG 
signal and normal ECG signal. In stage 3 (S3: 2890-2990 second), EEG activity became weaker 
and both the EEG and ECG signals exhibited relatively normal morphology. Stage 4 (S4: 3050-
3160 second) is marked by a reduction in the amplitude of EEG signals. During this stage, 
cardiac pacing rhythm dominated ECG. Interestingly, despite the pacing, the RRI jumped from 
0.81 second to 1.62 second in the middle of pacing (3115 seconds), which ended at 15.62 second 
as soon as the pacing stopped (3160 seconds). Stage 5 (S5: 3160-3260 second) is consisted of 
further reduced amplitude of EEG and ECG signals that were associated with third-degree heart 
blocks. During this phase, P-waves were undetectable. In stage 6 (S6: 3260-3420 second), there 
is a further attenuation of EEG signal and a partial recovery of heart rate from the stage 5 in ECG 
signal. It is worth mentioning that, the patient already had multiple episodes of cardiac arrest and 
was on life support by the end of S4 in this terminal cardiac arrest. The subtle increase of RRI 
between S3 and S4 was associated with the activation of cardiac pacemakers, which stopped 
momentarily. An additional mild increase of RRI preceding S4 was followed by a much longer 
duration of cardiac pacemaker activity during S4. The life support was removed at the end of S4,  
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Figure 3.1 EEG and ECG displayed series of activity with distinct features during the dying process. (A) 
EEG (from 19 cortical locations), ECG (lead II), and RR interval (RRI) during 1-hour terminal stage in 
the patient. The whole dying process was divided into 6 stages: stage 1 (S1: 700-800 sec), stage 2 (S2: 
2760-2890 sec), stage 3 (S3: 2890-2990 sec), stage 4 (S4: 3050-3160 sec), stage 5 (S5: 3160-3260 sec), 
and stage 6 (S6: 3260-3420 sec). (B) ECG and ECM display of raw signal from S3 to S6 (upper panels) 
and representative cardiac arrhythmias (middle panels) for each stage (lower panels). (C) Placement of 19 
EEG electrodes and classification of 12 channels into 4 clusters. LF: left frontal, RF: right frontal, LP: left 
posterior, RP: right posterior. 
which was associated with a sudden onset of bradycardia, with RRI rising from 1.62 seconds to 
15.62 seconds (see bottom panel in Figure 3.1A). From S5 onward, this patient was no longer on 
life support. Because the internal interactions between the brain and the heart is the focus of 
current study, S5 and S6 are the stages of major interests. To facilitate visualization, ECG signal 
from S3 to S6 was enlarged and aligned together with its corresponding ECM (Figure 3.1B). The 
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ECM for each stage (S3, S4, S5, and S6) is displayed in the lower panel of Figure 3.1B. 
Representative cardiac rhythms, which include peaked T wave in S3, cardiac pacing rhythm in 
S4, third-degree heart blocks in S5, and bradycardia in S6, were plotted and placed above the 
ECM (4 middle panels, Figure 3.1B). 
3.3.2 Recovery of EEG power at near-death 
EEG power analysis was conducted to investigate the dynamic changes of electrical activity in 
19 different cortical regions during the dying process. The temporal changes of EEG power from 
S2 to S6 for 4 representative channels F8, T5, Pz, and T6 are shown in Figure 3.2A. In S2, high 
level of EEG power was detected in right frontal channel F8, whereas relatively low level of 
EEG power was detected in left and right posterior channels T5 and T6. The EEG power for 
channel Pz located in the posterior midline is the lowest in S2. From S3 to S6, there was a large 
decrease of overall EEG power for all 4 channels compared to S2. For channel F8, there was a 
modest recovery of EEG power during the late S5 at high frequency ranges, as well as during S6 
for low frequencies. The EEG power for both T5 and T6 showed mild reduction in S3, and a 
transient recovery at late S4, and the early phase of S5 compared to S2. The EEG power showed 
further decline from the mid-S5 for high frequency rhythm for both channels, while the EEG 
power for low frequency showed a slight increase than previous stages. The EEG power for 
channel Pz was maintained at lowest level from S3 until asystole.  
To obtain a comprehensive understanding on the changes of EEG power for all 19 
channels during cardiac arrest, EEG power topography was plotted for each of the 6 stages 
(Figure 3.2B). As shown in the figure, during S1 and S2, high level of EEG power was detected 
for all 5 frequencies. The left and right frontal regions displayed higher EEG power than other 
regions. From S3 to S6, there was a dramatic decrease of overall EEG power for all frequencies. 
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Interestedly, on S4, there was still detectable EEG power on the left parietal and the right frontal 
regions for all frequency bands. On S5 and S6, EEG power was nearly undetectable for all 
channels at all frequencies except for S6 at theta rhythm, which showed an increase of EEG 
power on the left posterior and right frontal regions.  
 
Figure 3.2 Recovery of EEG power at near-death. (A) The spectrogram of EEG power for 4 
representative channels (F8, T5, Pz, and T6) from S2 to S6. (B) Topographic distribution of EEG power 
for 6 stages at 5 different frequency bands: delta (1-4Hz), theta (4-8Hz), alpha (8-13Hz), beta (13-25Hz), 
and gamma (25-55 Hz). 
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3.3.3 Increase of interhemispheric CCoh during cardiac arrest  
To investigate the functional synchronization between different cortical regions during cardiac 
arrest, CCoh analysis was performed for every 2 cortical channels. Figure 3.3A shows the 
temporal changes of CCoh for 4 representative cortical channel pairs during cardiac arrest. 
Functional connectivity in the dying brain exhibited clear spatial distribution. At lower frequency 
range (<30 Hz), the CCoh between F8 and Fp2 increases from S2 to S3, which further increases 
in S4 and S6. CCoh surge at higher range (30-65 Hz) in S4 coincided with the cardiac pacing. 
Intriguingly, the disappearance of this high frequency CCoh between F8 and Fp2 preceded the 
transition of ECG from sinus rhythms to 2nd degree heart block (Fig. 3.1B). The right posterior 
CCoh between T6 and P4 channels demonstrated a pattern nearly complementary to the right 
frontal CCoh, with much weaker CCoh at lower frequency (<25 Hz) in stages 4-6 and a stronger 
CCoh at higher frequency (>25 Hz) during S3 and the second half of S4 (Fig. 3.3A). In contrast, 
the left posterior CCoh between T5 and P3 channels, hemispherically symmetric to the CCoh 
between T6 and P4, demonstrated highest values at all five (S2-S6) stages. It is worth noticing 
that high levels of CCoh is not universally found in all regions of the brain, as the CCoh between 
right frontal channel F8 and posterior midline channel Pz was nearly undetectable during the 
entire process (Fig. 3.3A). These data demonstrate that functional connectivity within the 
cerebral cortex displays temporal and spatial specificity in dying human brain.  
To obtain a global view of the dynamic changes of CCoh during cardiac arrest, the mean 
coherence between every two of the 19 cortical channels was plotted for each of the 6 stages at 5 
frequencies. The CCoh displayed channel, frequency, and stage dependent changes. As shown in 
Figure 3.3B, from S1 to S3 at delta, theta, and alpha frequencies, the CCoh between adjacent 
channels was stronger than from distant channels, and the CCoh for lateral channels was stronger 
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than central channels. However, from S4 to S6, this ring-shaped coherence transformed into 
strong interhemispheric coupling between 3 channels in right frontal (F8, Fp2, and F4) and 3 
channels in left posterior regions (T5, O1, and P3). The 3 channels within each cluster also 
exhibited intense synchronization with each other. The interhemispheric coherence during S4-S6 
stages was stronger at theta and alpha frequencies and weaker at beta and gamma frequencies. 
 
Figure 3.3 Increase of interhemispheric cortical coherence (CCoh) at dear-death. (A) CCoh for 4 pairs of 
cortical channels (F8/Fp2, T5/P3, Pz/F8, and T6/P4) from S2 to S6. (B) Topographic distribution of CCoh 
for 6 stages at 5 different frequency bands: delta (1-4Hz), theta (4-8Hz), alpha (8-13Hz), beta (13-25Hz), 
and gamma (25-55 Hz). The width of edge indicates the level of coherence (0.4-0.9). 
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3.3.4 Increase of CCon at near-death 
To investigate how different cortical region communicates with each other during the dying 
process, feedforward (FF, from occipital/parietal to frontal regions) and feedback (FB, from 
frontal to parietal/occipital regions) CCon was measured for 12 pairs of cortical channels. The 12 
channels were first divided into 4 clusters (LF, RF, LP, and RP), each of which contains 3 
channels (Figure 3.1C). The FF and FB CCon between the 3 channels in LF and RP, as well as 
between the 3 channels in RF and LP was calculated. Figure 3.4A shows the FF and FB CCon 
for 2 representative cortical channel pairs. As shown in the left panel (F8/T5), there was increase 
during S6 in both FF and FB CCon between F8 and left posterior channel T5 during S6 for delta, 
theta, and gamma rhythm. In alpha frequency, the stage that showed high level of CCon was S4, 
whereas CCon for beta rhythm showed elevated levels only during S2 phase, which remained 
rather flat for the remainder of the recording. For gamma rhythms, however, even though 
coherence value was relatively low between F8 and T5, the causal connectivity (CCoh) reached 
the highest levels in stage S6, immediately before cardiac arrest. The FB and FF CCon for right 
frontal channel F8 and left posterior channel O1 exhibited similar dynamic as F8 and T5.  
FF and FB CCon between every 2 channels from diagonal clusters for each stage exhibit 
dynamic changes in the dying brain (Fig. 3.4B). At delta frequency, FF and FB CCon were 
maintained at low level with small fluctuations from S1 to S6. For theta and alpha bands, there 
were active FF and FB communications between the 4 clusters in S1, S2 (only alpha), S4, and 
S6. During other stages, only sporadic activity was detected in a few channels, including Fp1/T6, 
O2/F7 (FB), F8/T5 (FF), and Fp1/P4 (FF). In addition, the CCon surge in S1, S2, and S6 
demonstrated distinct patterns. In S1 and S2, the most active channels are O1/F8 (FB), F8/T5 
(FF), Fp1/O2 (FF), Fp1/T6 (FF), F7/O2 (FF), P3/F4, and T5/F4. In S6, the most active channels 
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are F8/T5 (FF), T6/Fp1 (FB), F3/P4 (FF), F3/T6 (FF), Fp1/P4 (FF), and Fp1/T6 (FF). For beta 
and gamma oscillations, FF and FB CCon between F4 and 3 channels in LP clusters was high 
during S1 and S2. The CCon for all the channels at beta frequency then declined from S3 to S6. 
At gamma band, the CCon was low from S3 until S5. However, at S6, there was a marked surge 
of FB CCon between LP and RF clusters. 
 
Figure 3.4 Increase of cortical directional connectivity (CCon) at near-death. (A) CCon for 2 pairs of 
cortical channels (F8/T5 and F8/O1) from S2 to S6 at 5 different frequencies: delta (1-4Hz), theta (4-
8Hz), alpha (8-13Hz), beta (13-25Hz), and gamma (25-55 Hz). FF: feedforward (occipital/parietal to 
frontal regions). FB: feedback (frontal to parietal/occipital regions). (B) The CCon between 12 EEG 
channels for 6 stages at 5 different frequencies. 
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3.3.5 Surge of cardiac event-related potential (CERP) at near-death 
To investigate the possible interactions between the brain and the heart during cardiac arrest, raw 
EEG and ECG signals were first converted into matrix format (Li et al., 2015a; 2015b) and 
aligned together. Figure 3.5A shows the ECM and EEM for 4 representative cortical channels, 
F8, T5, Pz, and T6, from S2 to S6. No obvious phase relationships were identified between ECM 
and EEM for all 4 cortical channels during S2 and S3. From S4 to S6, however, signals from 
right frontal channel F8 and left posterior channel T5 synchronized with ECG signal and showed 
cardiac event-related potential (CERP), which was strongest during S6. In contrast, CERP was 
undetectable for channel Pz located in posterior midline from S4 to S6 and was only identifiable 
for right posterior channel T6 during S6. To make a clearer comparison between the CERP from 
F8 and T5, two 40-second-long epochs were selected from S4 and S6 (red bars in Figure 3.5A) 
and placed side by side with the ECM (Figure 3.5B). As shown in the figure, ECG and F8 
displayed positive peaks with similar amplitude during S4. However, during S6, the R-peak of 
F8 was much more positive than the corresponding ECG signal. For both S4 and S6, left 
posterior channel T5 exhibited strong negative peaks. When the raw ECG and EEG signals were 
averaged over the 40 sec epoch and plotted together (right panels in Figure 3.5B), similar 
amplitude relationship among ECG, F8, and T5 were found for both S4 (top graph) and S6 
(bottom graph). Interestingly, ECG and EEG signals demonstrated distinctive phase relationship 
at two different stages. During S4, very little time delay was found for peak potentials from F8 
and T5 channels compared to the peak of heartbeat, whereas an 18-ms time delay was identified 
for peak potentials from both F8 and T5 during S6. EEM for all 19 EEG channels arranged 
according to their locations on the skull during S4 and S6 is shown in Supplement Figure 2 and 
Supplement Figure 3 in Appendix.   
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Figure 3.5 Surge of cardiac event-related potential (CERP) at near-death. (A) ECM and EEM for ECG 
and 4 representative cortical channels (F8, T5, Pz, and T6) from S2 to S6. (B) Alignment of ECM (left 
panel) with EEM for 2 cortical channels, F8 (middle left) and T5 (middle right), for 2 epochs (red bars in 
A, S4: 3060-3100 sec, S6: 3330-3370 sec). CERP for F8 (blue trace) and T5 (black trace) was averaged 
and displayed along with the averaged heartbeat (red trace) in right panel.  
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3.3.6 Surge of CCCoh at near-death 
The detection of CERP stimulated the investigation on the functional coupling between the brain 
and the heart at near-death. CCCoh was calculated between each of the 19 EEG channels and the 
ECG signal. Figure 3.6A shows the temporal dynamics of the functional connectivity between 
ECG and 4 representative EEG channels F8, T5, Pz, and T6. In S2 and S3, very little CCCoh 
was detected between the 4 cortical channels and the ECG. From S4 until cardiac asystole, there 
is a dramatic surge of CCCoh at low frequencies (<30 Hz) for both right frontal channel F8 and 
left posterior channel T5, with higher frequency (>30 Hz) CCCoh seen during S4 for both 
channels. For channel Pz located in the posterior midline, no CCCoh was identified during the 
entire process. A weak CCCoh was detected for right posterior channel T6 at S4 and S6 at low 
frequency ranges. To obtain a comprehensive understanding on the dynamic changes of CCCoh 
between 19 cortical regions and the heart during the dying process, CCCoh for 19 channels was 
calculated for each of the 6 stages and plotted in a topographic format for 5 frequencies (Figure 
3.6B). No detectable or marginal level of CCCoh was identified for all the channels from S1 to 
S3. Remarkable level of CCCoh was identified at 3 near-death stages: S4, S5, and S6. Among all 
19 cortical regions, the left parietal, left occipital, and right frontal lobes are the main cortical 
regions that synchronize with the cardiac signals during cardiac arrest. In addition of exhibiting 
temporal (S1-S6) and spatial (channels 1-19) specificity, CCCoh is also frequency specific. In 
high frequency bands (beta and gamma), only low level of CCCoh was detected for a few 
channels (F8/ECG and T5/ECG) during S4. High level of CCCoh was clustered mainly at theta 
and alpha frequencies. 
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Figure 3.6 Surge of corticocardiac coherence (CCCoh) at near-death. (A) CCCoh between 4 cortical 
channels (F8, T5, Pz, and T6) and ECG from S2 to S6. (B) Topographic distribution of CCCoh for 6 
stages at 5 different frequency bands: delta (1-4Hz), theta (4-8Hz), alpha (8-13Hz), beta (13-25Hz), and 
gamma (25-55 Hz). 
3.3.7 Surge of CCCon at near-death 
To investigate the directional information flow between the brain and the heart during the dying 
process, CCCon analysis was conducted between each of the 12 EEG channels and ECG signal. 
Figure 3.7A shows the CCCon between representative cortical channels (F8 and T5) and the 
ECG signal. Afferent connectivity (from the heart to the brain, or feedforward, or FF) to the right 
frontal cortex (F8) from the heart is strong at both delta and theta frequency bands specifically at 
the terminal S6 stage, and is evident for alpha and beta bands only during the early phase of S4  
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Figure 3.7 Surge of corticocardiac directional connectivity (CCCon) at near-death. (A) CCCon between 2 
cortical channels (F8 and T5) and ECG from S2 to S6 at 5 different frequencies: delta (1-4Hz), theta (4-
8Hz), alpha (8-13Hz), beta (13-25Hz), and gamma (25-55 Hz). FF: feedforward (heart to brain). FB: 
feedback (brain to heart). (B) The CCCon between 12 EEG channels and ECG for 6 stages at 5 different 
frequency bands. 
prior to the onset of 2nd degree heart block. Efferent connectivity (from the brain to the heart, or 
feedback, or FB) is elevated during stage 6 for multiple frequency bands below alpha bands and 
uniquely seen for beta bands in S1 and for gamma band at multiple time points (S3-S6). Afferent 
signaling from the heart to the left posterior cortex at T5 (Figure 3.7A, right panels) exhibited a 
pattern similar to that of F8. Notable exception was the temporal distribution of CCCoh at 
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gamma frequency, which is specific for S6 states in both directions at T5 locus, whereas a wider 
distribution of gamma connectivity across stages S3-S6 is found at F8 locus (Figure 3.7A, left 
panels). Additional notable feature includes that (1) efferent brain-heart connectivity dominates 
over afferent heart-brain connectivity for gamma band and (2) at lower frequency bands (lower 
than beta frequency), opposite appears to be true: afferent connectivity is more dominant. The 
CCCon between each of the 12 cortical channels and the heart were calculated for each stage at 5 
frequencies (Figure 3.7B). FF and FB CCCon exhibited stage-, frequency-, and channel-
dependent changes during cardiac arrest. As shown in the figure, marked surge of CCCon was 
detected at S6 for delta and theta bands, S4 for alpha band, S1 and S2 for beta band, and S4, S5, 
S6 for gamma frequency. From S1 to S2, CCCon on both directions was maintained at similar 
basal level for all the channels at delta, theta, alpha, and gamma frequencies. On beta band, the 
FB CCCon was higher for right frontal and left posterior channel F4, T5, O1, and O2 than other 
channels. During S3, the FF CCCon for left posterior channels T5 and O1 was higher than other 
channels from theta to beta rhythm. The CCCon on delta and gamma bands remained at low 
level for all channels. From S4 to S6, there was a gradual decline of CCCon for all the channels 
at beta rhythm. In contrast, there is a dramatic surge of CCCon for delta, theta, and alpha 
oscillations occur at S6, S6, and S4, respectively, with FF CCCon domination. The most active 
channels are right frontal and left posterior channel F8, T5, and O1 for FF CCCon and left 
frontal and posterior channel F7, T5, and O1 for FB CCCon. However, for high frequency 
gamma rhythm, the surge of CCCon was identified during S4, S5, and S6 with FB domination. 
The most active FB channels are right frontal and left posterior channel F4, F8, and O1, whereas 
the most active FF channels are right frontal and right posterior channel F4, T5, and O2.  
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3.3.8 Summary of findings 
During cardiac arrest, there are ordered change of RRI and decrease of EEG power. A marked 
surge of coherence and connectivity both within the brain and between the brain and the heart are 
identified at near-death stages. Marked increase of cortical coherence and connectivity indicates 
that the brain is internally highly activated. Marked increase of corticocardiac coherence and 
connectivity indicates that there are strong electrical signal coupling and communication 
between the brain and the heart in the dying phase. The brain regions that are mainly responsible 
for cortical control of cardiac function during sudden cardiac arrest appear to include the right 
frontal and left parietal lobes.  
 
Figure 3.8 Summary of findings. RRI: RR interval, NSTE: normalized symbolic transfer entropy. 
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3.4 Discussion 
In this study, we investigated the dynamic changes of electrical activities of the brain, the heart, 
and the functional electrical interactions between the brain and the heart in a human patient 
before and after sudden cardiac failure. Consistent with previous findings in asphyxia cardiac 
arrest rat model, a marked surge of coherence and connectivity was identified both within the 
brain and between the brain and the heart in this human patient at near-death. However, different 
from the rat model, coherence and connectivity in human patient showed changes unique to 
particular frequency ranges and cortical areas, especially the low frequencies in right frontal and 
left posterior lobes, suggesting that the low frequency oscillations in these two brain regions may 
play an important role in cortical control of the cardiac function during sudden cardiac arrest. 
This result indicates that strong brain-heart connection might be a common mechanism for 
sudden cardiac arrest in both rats and human.  
3.4.1 Deterioration of the heart and activation of the brain at near-death 
Many previous studies suggest that the abnormal interactions between the brain and the heart 
may be the mechanism underlying sudden cardiac arrest [Samuels, 2007; Dorrance and Fink, 
2015; Gonzales-Portillo et al., 2016]. However, the dynamic changes of the brain, the heart, and 
interactions between the two vital organs have not been studied in any human cardiac arrest 
cases before. In current study, we monitored the electrical activity of the brain and the heart 
simultaneously during sudden cardiac failure in a human patient, and investigated the functional 
changes as well as the potential interactions between the brain and the heart during the dying 
process. Analysis of the RRI and cardiac arrhythmias revealed that the heart underwent similar 
changes at near-death in human patients as in asphyxic cardiac arrest rat models.  
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EEG signals of this patient displayed a series of dynamic functional changes before 
asystole. The functional coupling and directional information transfer between different cortical 
region was investigated. Consistent with earlier findings from KCl injection and asphyxia-
induced cardiac arrest rat model [Borjigin et al., 2013; Li et al., 2015a], a marked surge of 
coherence and directional connectivity was identified within the brain at near-death. Unlike rat 
studies, however, the CCoh and CCon in the human patient showed a remarkable spatial 
specificity. Upon progressing to S4 from S3, the CCoh transitioned from intra-hemispheric to 
strong interhemispheric patterns of coherence between left posterior and right frontal regions at 
delta, theta, and alpha frequency. During the same transition, the CCon also showed a surge 
between left and right frontal region at delta, theta, alpha, and gamma oscillations. In contrast, in 
KCl injection-induced cardiac arrest model, the surge of CCoh and CCon was only identified in 
theta and gamma frequency band. In addition, in asphyxic cardiac arrest model, there is a 
dramatic increase of CCoh and CCon from theta to gamma rhythm. Currently, it is still unknown 
how the cortical signal communication switched from a diffused pattern to strong 
interhemispheric coherence and connectivity. Nevertheless, the recovery of EEG power, and 
marked surge of CCoh and CCon indicates that a highly-activated brain at near-death is 
conserved between rats and human.  
3.4.2 Asymmetrical distribution of CERP during sudden cardiac arrest  
To investigate the coupling between the brain and the heart, raw EEG and ECG signals were 
converted into a matrix format and aligned together to facilitate identification of interesting 
patterns. We found a surge of CERP at near-death stages. Interestingly, the CERP demonstrated 
asymmetrical patterns over the cerebral cortex. On the right side of the brain, the CERP 
displayed positive relationship with ECM, whereas on the left side of the brain, the CERP 
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showed negative relationship with ECM. And the right frontal and left parietal regions showed 
the most positive and negative CERPs. The asymmetrical distribution of CERP among the cortex 
may be associated with the hemisphere asymmetry in autonomic control of the heart. It is known 
that neural control of the heart is mediated by the sympathetic and parasympathetic nervous 
pathways innervating the heart [Schwartz and De Ferrari, 2011]. Evidence suggests that the right 
hemisphere of the brain is predominantly concerned with sympathetic activity, whereas the left 
hemisphere is predominantly concerned with parasympathetic activity [Lane and Jennings, 1995; 
Wittling et al., 1998]. Autonomic nerves from the brain to the heart are mostly symmetrical 
[Levy et al., 1966; Yanowitz et al., 1966; Randall and Ardell, 1990]. These form the basis for the 
laterality hypothesis whereby central neural processes may be represented asymmetrically on the 
heart [Lane and Jennings, 1995; Lane et al., in press]. However, in rat models, CERP did not 
display asymmetrical distribution among the cortex. The spatial specificity of CERP in human 
brain may due to the fact that the human brain is more evolved than rats, so that different cortical 
regions in human brain may be specialized to exert limited functions or perform specific tasks, 
which include the regulation of cardiac function through the autonomic nervous pathways. 
Except for hemispheric specificity, CERP also demonstrated distinct temporal patterns at 
different stages. A 18-ms time delay was identified for the CERP from both right frontal channel 
F8 and left posterior channel T5 in middle cardiac arrest S4 than later cardiac arrest S6. Based on 
these results, we made the hypothesize that the afferent information from the heart may be first 
received by the right side of the brain, and the efferent information to the heart may be sent out 
from the left side of the brain. The strong coherence and directional connectivity between the left 
posterior and right frontal region may be explained by that the brain is integrating and processing 
the cardiac information in order to perform internal resuscitation to save the heart. With the 
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progression of cardiac arrest, the brain-heart communicating is becoming less effective, which is 
indicated by a longer time-delay in later cardiac arrest S6. 
3.4.3 Role of left posterior and right frontal regions in cortical control of cardiac function 
Using the same signal processing approaches in rat models, we identified a dramatic increase of 
coherence and directional connectivity between the brain and the heart at near-death in human 
patient. The consistency of current study with previous study indicates that corticocardiac 
coupling may be a common mechanism underlying sudden cardiac arrest in human and rats. 
However, there are differences of CCCoh and CCCon between asphyxic cardiac arrest rat model 
and human patient. While no hemispheric specificity was identified for CCCoh and CCCon in rat 
models, CCCoh and CCCon in human patient is clustered in left posterior and right frontal 
regions. In addition, the surge of CCCoh and CCCon was detectable from delta to gamma 
frequencies in rat models. However, in human patient, CCCoh and CCCon mainly appeared at 
theta and alpha frequencies. The asymmetrical topographic distribution and frequency specificity 
of CCCoh and CCCon suggest a different and potentially more complex mode of interaction 
between the brain and the heart in humans than in rats. Till now, it is unclear how the right 
frontal and left posterior regions communicate with the heart at near-death. But these two brain 
regions are close to the insular cortex and prefrontal cortex, which have been shown to be 
involved in the cortical control of the cardiac function using fMRI or cortical stimulation 
[Napadow et al., 2008; Oppenheimer et al., 1990; Critchley et al., 2003; Palma and Benarroch, 
2014; Thayer and Lane, 2009; Gianaros and Sheu; 2009]. More recently, another study 
demonstrated that in humans, neural events locked to heartbeats before stimulus onset predict the 
detection of visual grating in the posterior right inferior parietal lobule and the ventral anterior 
cingulate cortex [Park et al., 2014], which is near to the right frontal region in our study. Another 
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study measuring the changes in cardiac response in patients with established ventricular 
dysfunction demonstrated that the amplitude of heart-beat-evoked potential at left temporal and 
lateral frontal regions correlated with stress-induced changes in cardiac output, which is 
consistent with the two super-activated cortical regions we identified at near-death. In addition, 
the amplitude of the heart-beat-evoked potential in the left temporal region reflected the pro-
arrhythmic status of the heart [Gray et al., 2007]. Results from the above studies suggest that left 
posterior and right frontal regions may play an important role for cortical control of the heart. 
Future studies with multiple electrodes implanted in cortical and subcortical regions, as well as 
brainstem may provide a more precise estimation of key regions or pathways that mediate brain-
heart connection during the dying process. 
3.4.4 Corticocardiac coupling as a conserved mechanism for sudden cardiac arrest 
In previous studies, we showed that both experimental cardiac arrest and ischemic cardiac arrest 
stimulated a marked surge of coherence and connectivity in the brain as well as between the 
brain and the heart before sudden death in rat models [Borjigin et al., 2013; Li et al., 2015a]. 
Combined with the microdialysis results, we proposed that during the asphyxic cardiac arrest, the 
right hemisphere of the brain sends strong electrical signals to the heart and causes premature 
and rapid deterioration of the cardiac function via the activated sympathetic nervous system. In 
human patient, we found that there are ordered change of RRI and decrease of EEG power in the 
dying process. A recovery of EEG power and marked surge of coherence and connectivity both 
within the brain and between the brain and the heart are identified at near-death. Marked increase 
of CCoh and CCon indicates that the brain is internally highly activated. Marked increase of 
CCCoh and CCCon indicates that there are strong electrical signal coupling and communication 
between the brain and the heart in the dying process. The brain regions that are mainly 
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responsible for cortical control of cardiac function during sudden cardiac arrest are the right 
frontal and left parietal lobes. Current study in human patient successfully reproduced the results 
obtained in rat models, suggesting that corticocardiac coupling may be a conserved mechanism 
for sudden cardiac arrest induced by different causes. Nevertheless, the asymmetrical 
topographic distribution of CCCoh and CCCon suggest a potentially more complex mode of 
interaction between the brain and the heart in humans than in rats. As the next step, we plan to 
perform signal analysis for more human patients to further validate our hypothesis.  
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Chapter 4 Intermittent surge of corticocardiac coupling preceding to sudden death in 
ischemic rats  
 
4.1 Introduction 
Sudden death is an important but under-recognized consequence of stroke [Sörös and Hachinski, 
2012]. Despite major improvements in stroke diagnosis and treatment, 2-6% of patients suffer 
from sudden, unexpected death within the first 3 months after ischemic stroke [Prosser et al., 
2007; Sörös and Hachinski, 2012]. In addition, about 19% of patients have fatal or serious non-
fatal cardiac events, such as ventricular arrhythmias, which greatly increase the risk of sudden 
death [Prosser et al., 2007; Frangiskakis et al., 2009; Sörös and Hachinski, 2012]. The 
mechanisms of ischemic stroke-induced sudden death remain unclear. As a consequence, 
identification of patients at risk and prevention of stroke-induced sudden death present a major 
challenge.  
Our laboratory has discovered that the brain is highly activated immediately following 
global ischemia induced by experimental cardiac arrest [Borjigin et al., 2013]. More recently, we 
reported a marked surge of functional connectivity (cortical coherence, CCoh) and directional 
connectivity (CCon) in the dying brain of rats following asphyxia, which paralleled with 
excessive cortical release of a set of core neurotransmitters [Li et al., 2015a]. In addition to the 
changes within the brain, a surge of corticocardiac coherence (CCCoh) and directional 
connectivity (CCCon), indicator for strong brain-heart connection, emerged after the onset of 
asphyxia with a reliable time delay [Li et al., 2015a]. These data suggest that sudden death in rats 
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that suffered global ischemia is tightly associated with the surge of functional connectivity 
within the cortex as well as between the cortices and the heart. Whether this association exists in 
dying rats with forebrain ischemia is unknown.  
Bilateral common carotid artery ligation (BCCAL) in stroke-prone spontaneously 
hypertensive rat (SHRSP) is a well-established model for forebrain ischemia [Kakihana et al., 
1983; Lobanova et al., 2008]. The cerebrovascular architecture and risk factors in SHRSP 
resemble with stroke in human patients, which makes SHRSP, derived from the normotensive 
Wistar-Kyoto (WKY) rat, a suitable model for studying ischemic stroke in rats [Yamori et al., 
1976]. Compared to asphyxic cardiac arrest rat model used in our previous studies, in which the 
entire body, including the brain and heart, is globally affected, the forebrain ischemia model 
(BCCAL) tests the direct influence of brain ischemia on cortical/cardiac functions, and permits 
the dissection of functional communication between the two vital organs. In this study, we use 
advanced signal processing techniques to functionally characterize the brain and the heart in the 
BCCAL model. Our goal is to understand how neurological injuries lead to abnormal brain-heart 
connection, autonomic dysfunction, cardiac damage, and sudden death. Ultimately, we hope this 
line of investigation will contribute to better understanding of the dying brain and the 
development of novel non-invasive biomarkers for prediction of risk for sudden death. 
4.2 Materials and methods 
4.2.1 Animals  
Inbred SHRSP and WKY rats were acclimatized in our housing facility for at least 1 week before 
implantation of electrodes. Following electrode implantation, rats were allowed to recover for 1 
week before online recording. The experimental procedures were approved by the University of 
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Michigan Committee on Use and Care of Animals. All experiments were conducted using adult 
rats (300-400 g) maintained on a light: dark cycle of 12: 12 hour (lights on at 6:00 am) and 
provided with ad libitum food and water.  
4.2.2 Electrode implantation and configuration 
Rats were implanted with electrodes for EEG signal recording under surgical anesthesia [1.8% 
(vol/vol) isoflurane]. The EEG signals were recorded through screw electrodes implanted 
bilaterally on the frontal [anteroposterior (AP): + 3.0 mm; mediolateral (ML): ± 2.5 mm, 
bregma], parietal (AP: -3.0 mm; ML ± 2.5 mm, bregma), and occipital (AP: -8.0 mm; ML: ± 2.5 
mm, bregma) cortices. The ECG signals were recorded through flexible and insulated (except at 
the tip) multi-stranded wires (Cooner Wires, Chatsworth, CA) inserted into subcutaneous 
muscles flanking the heart. The EEG and ECG electrodes were interfaced with two six-pin 
pedestals (Plastics One, Roanoke, VA), and the entire assembly was secured on the skull using 
dental acrylic.   
4.2.3 Signal acquisition and stroke surgeries 
Prior to data collection, rats were acclimatized in the recording chamber. EEG and ECG signals 
were recorded using Grass Model 15LT physiodata amplifier (15A54 Quad amplifiers) system 
(Astro-Med, Inc., Quincy, MA) interfaced with BIOPAC MP-150 data acquisition unit and 
AcqKnowledge software (version 4.1.1, BIOPAC systems, Inc., Goleta, CA). The signals were 
filtered between 0.1 and 300 Hz and sampled at 1,000 Hz. EEG and ECG recordings were 
initiated consistently at 10:00 am to control for circadian factors. Baseline signals were recorded 
for 1 hour. At the end of this baseline recording, permanent BCCAL was performed for SHRPS 
and WKY rats under surgical anesthesia [Ogata et al., 1976]. After BCCAL, recording was 
continued until sudden death for SHRSP rats and for at most 24 hours for WKY rats. 
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4.2.4 Analysis of RR interval (RRI), cardiac arrhythmias, and heart rate variability (HRV)  
To analyze the RRI, baseline drift correction was first implemented using second-order 
Butterworth high-pass filtering with a cutoff frequency at 1 Hz (butter.m and filtfilt.m in Matlab 
Signal Processing Toolbox; MathWorks Inc., Natick, MA). R peaks of ECG signals were then 
detected using variable threshold method [Kew and Jeong, 2011]. Specifically, an amplitude 
threshold in each nonoverlapping 1 second epoch was applied to select the candidates for R 
peaks, which can be verified only if the RRI value exceeds a predefined threshold. In this study, 
the interval threshold was selected as half of the median value of the RRI values in the last 1 
second epoch. The automatically detected R peaks were manually validated through a custom 
user interface developed in Matlab (MathWorks Inc., Natick, MA). As the next step, outliers 
were removed from the validated RRI using threshold and sliding window averaged filter. RRI 
was then interpolated using linear interpolation for every 1 minute and plotted for SHRSP and 
WKY rats (Figure 4.1B). The mean and standard deviation of RRI during baseline (1 hour before 
BCCAL), first hour (1st hour after BCCAL), and last hour (1.5-0.5 hour before death) were 
calculated for all SHRPS (n=9) and WKY (n=8) rats (Figure 4.1C). To analyze the number and 
types of cardiac arrhythmias, ECG signals were examined and cardiac arrhythmias were 
manually labeled and counted using a custom user interface developed in Matlab (MathWorks 
Inc., Natick, MA). 
HRV was analyzed to study the interactions between the sympathetic and 
parasympathetic nervous system. While high frequency (HF) is considered to reflect 
parasympathetic activity, low frequency (LF) is thought to be affected by both the sympathetic 
and parasympathetic activity [Kuwahara et al., 1994]. The ratio between LF and HF (LF/HF) 
reflects the relative balance of sympatho-vagal influences on the heart. Frequency domain 
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analysis of HRV was performed using Fast Fourier transform for LF (0.25-0.8 Hz) and HF (0.8-3 
Hz). Frequency selection was based on previous works in rats [Fauchier et al., 2006; Barbosa et 
al., 2013]. The power spectrum of HRV was calculated and expressed in log scale for SHRSP 
and WKY rats (Figure 4.6A). The mean and standard deviation of power spectral density for LF, 
HF, and LF/HF during baseline (1 hour before BCCAL), first hour (1st hour after BCCAL), and 
last hour (1.5-0.5 hour before death) were calculated for all SHRPS (n=9) and WKY rats (n=8) 
(Figure 4.6B).  
4.2.5 Construction of electrocardiomatrix (ECM) 
The ECM is designed to facilitate the visualization of RRI, the amplitude, and the morphology of 
ECG signals. For construction of ECM [Li et al., 2015b] , a window centered on the detected 
ECG R peaks (for example, from -0.1 second to 0.3 second, with 0 corresponding to the time of 
R-peak) was extracted from the ECG signal after baseline drift correction. All ECG windows 
were sorted according to the order of R-peak time and then plotted as parallel colored lines to 
form a colored rectangular image. The intensity of ECG signal was denoted on z-axis, with 
warmer color indicates positive peaks with higher voltage, while cooler color indicates negative 
peaks with lower voltage. The color scheme could be adjusted according to the need.  
4.2.6 Analysis of EEG power 
The original sampling frequency of 1,000 Hz was first down-sampled to 500 Hz to reduce 
computing time. A notch filter was used to remove the 60 Hz artifact and its possible super-
harmonics. Then EEG power was analyzed using short time Fourier transform based on discrete 
Fourier transform with 2-second segment size and 1 second overlapping for each frequency bin 
(0.5-250 Hz with 0.5 Hz bin size; spectrogram.m in Matlab Signal Processing Toolbox, 
96 
 
MathWorks Inc., Natick, MA). Each segment was windowed with a Hamming window. The 
absolute EEG power was expressed on a log scale for SHRSP and WKY rats (Figure 4.2A). The 
absolute EEG power on gamma 1 frequency was summed up and plotted for SHRSP and WKY 
rats (Figure 4.2B). The mean and standard deviation of absolute EEG power during baseline (1 
hour before BCCAL), first hour (1st hour after BCCAL), and last hour (1.5-0.5 hour before 
death) was calculated for six frequency bands: delta (0.5-5 Hz), theta (5-10 Hz), alpha (10-15 
Hz), beta (15-25 Hz), gamma 1 (25-55 Hz), and gamma 2 (65-115 Hz) for all SHRPS (n=9) and 
WKY (n=8) rats (Figure 4.2C).  
4.2.7 Analysis of CCoh and CCCoh 
The coherence between 6 EEG channels (CCoh), or between 1 ECG and 6 EEG channels 
(CCCoh) was measured by amplitude squared coherence (𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓)) (mscohere.m in Matlab Signal 
Processing Toolbox, MathWorks Inc., Natick, MA), which is a coherence estimate of the input 
signals x and y using Welch’s averaged, modified periodogram method. The magnitude squared 
coherence estimate 𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) is a function of frequency with values between 0 and 1 that indicates 
how well signal x corresponds to signal y at each frequency: 
𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) = �𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓)�2𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓)𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓), 0 ≤ 𝐶𝐶𝑥𝑥𝑥𝑥(𝑓𝑓) ≤ 1   (1) 
where 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) and 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) are the power spectral density of x and y, and 𝑃𝑃𝑥𝑥𝑥𝑥(𝑓𝑓) is the cross power 
spectral density.   
In current study, a notch filter was used to remove the 60 Hz artifact and its possible 
super-harmonics. EEG or ECG signals were then segmented into 2-second epochs with 1-second 
overlap. The magnitude squared coherence was calculated at each epoch and frequency bin (0.5-
250 Hz with 0.5 Hz bin size). The mean coherence between 6 EEG channels (Figure 4.3A) and 
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among 1 ECG and 6 EEG channels (Figure 4.4A) were calculated and plotted for frequencies 
from 0.5 to 250 Hz for SHRSP and WKY rats. The mean CCoh (Figure 4.3B) and CCCoh 
(Figure 4.4B) for gamma 1 frequency band were also plotted for SHRSP and WKY rats. The 
mean and the standard deviation of coherence among 15 pairs of 6 EEG channels during baseline 
(1 hour before BCCAL), first hour (1st hour after BCCAL), and last hour (1.5-0.5 hour before 
death) were calculated for frequencies from delta to gamma 2 for all SHRPS (n=9) and WKY 
(n=8) rats (Figure 4.3C). The mean and the standard deviation of percent changes on the 
amplitude of CCCoh over baseline were calculated for each hour after BCCAL and compared 
between SHRSP (n=9) and WKY (n=8) rats (Figure 4.4C, left panel). The duration of epochs 
with CCCoh 2 times higher than baseline was summed up for each rat and expressed as a 
percentage of the total duration for that rat. Comparison was then made between SHRSP (n=9) 
and WKY (n=8) rats for all 6 frequencies (from delta to gamma 2) (Figure 4.4C, right panel). 
4.2.8 Analysis of CCCon 
The directional connectivity between EEG and ECG signals was measured by modified [Li et al., 
2015a] Normalized Symbolic Transfer Entropy (NSTE) [Lee et al., 2009], which is a nonlinear 
and model-free estimation of directional functional connection based on information theory. STE 
measures the amount of information provided by the additional knowledge from the past of the 
source signal X(𝑋𝑋𝑃𝑃) in the model describing the information between the past Y(𝑌𝑌𝑃𝑃) and the 
future Y(𝑌𝑌𝐹𝐹) of the target signal Y, which is defined as following: 
𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌 = 𝐼𝐼(𝑌𝑌𝐹𝐹;𝑋𝑋𝑃𝑃|𝑌𝑌𝑃𝑃) = 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) − 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑋𝑋𝑃𝑃,𝑌𝑌𝑃𝑃)   (2) 
where 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) is the entropy of the process 𝑌𝑌𝐹𝐹conditional on its past. Each vector for 
𝑌𝑌𝐹𝐹 ,𝑋𝑋𝑃𝑃 𝑎𝑎𝑎𝑎𝑎𝑎 𝑌𝑌𝑃𝑃is a symbolized vector point. The potential bias of STE was removed with a 
shuffled data, and the unbiased STE is normalized as follows:  
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𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌
 = 𝑆𝑆𝑆𝑆𝑆𝑆𝑋𝑋→𝑌𝑌−𝑆𝑆𝑆𝑆𝑆𝑆𝑋𝑋→𝑌𝑌𝑆𝑆ℎ𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢 
𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌  ) ∈ [0, 1]   (3) 
where 𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌
𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑢𝑢𝑢𝑢𝑢𝑢 = 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃) − 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑋𝑋𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑃𝑃 ,𝑌𝑌𝑃𝑃).   𝑋𝑋𝑆𝑆ℎ𝑢𝑢𝑓𝑓𝑓𝑓𝑃𝑃  is a shuffled data created by 
dividing the data into sections and rearranging them at random. Therefore, NSTE is normalized 
STE (dimensionless), in which the bias of STE is subtracted from the original STE and then 
divided by the entropy within the target signal, 𝐻𝐻(𝑌𝑌𝐹𝐹|𝑌𝑌𝑃𝑃). 
For CCCon, the feedback connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸) was calculated by averaging 
NSTE over 6 pairs of EEG channels to ECG channel, which are defined as follows: 
𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸 = 1𝑛𝑛𝐸𝐸𝐸𝐸𝐸𝐸 ∑ 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑖𝑖→𝑆𝑆𝐸𝐸𝐸𝐸𝑛𝑛𝐸𝐸𝐸𝐸𝐸𝐸𝑖𝑖=1    (4) 
where 𝑎𝑎𝑆𝑆𝑆𝑆𝐸𝐸 = 6. The feedforward connectivity (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝐸𝐸𝐸𝐸→𝑆𝑆𝑆𝑆𝐸𝐸) from the ECG to 6 EEG 
channels is vice versa. 
Specifically, we first filtered EEG and ECG signals into 6 frequency bands (from delta to 
gamma 2), and then segmented the filtered signals into 2-second long epochs with 1-second 
overlapping. The mean CCCon (𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝑆𝑆𝐸𝐸→𝑆𝑆𝐸𝐸𝐸𝐸  and 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇��������𝑆𝑆𝐸𝐸𝐸𝐸→𝑆𝑆𝑆𝑆𝐸𝐸) were sequentially calculated 
for each epoch and each frequency band. Three parameters: embedding dimension (𝑎𝑎𝑆𝑆), time 
delay (τ), and prediction time (𝛿𝛿), were required in the calculation. In this study, we selected the 
parameter setting that could yield maximum 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑋𝑋→𝑌𝑌  by fixing the embedding dimension (𝑎𝑎𝑆𝑆) 
at 3, and optimizing prediction time 𝛿𝛿 (from 1 to 50, corresponding to 1-50 ms with the sampling 
frequency of 1,000 Hz) and time delay 𝜏𝜏 (1-300 ms). The same procedure was used to 
calculate 𝑁𝑁𝑆𝑆𝑇𝑇𝑇𝑇𝑌𝑌→𝑋𝑋 , provided that the information between two signals is transferred through 
different neuronal pathway. The feedback and feedforward CCCon were plotted for theta and 
gamma 1 frequency for a sample epoch that shows a surge of CCCoh (Figure 4.5A). The mean 
and standard deviation of CCCon epochs during baseline (1 hour before BCCAL), first hour (1st 
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hour after BCCAL), and last hour (1.5-0.5 hour before death) was calculated for six frequency 
bands for all SHRPS (n=9) rats (Figure 4.5B).  
4.2.9 Statistical analysis 
For all the statistical analyses, Shapiro-Wilk normality test was first implemented to determine if 
the data was normally distributed. To test the differences of RRI (Figure 4.1C), EEG power 
(Figure 4.2C), CCoh (Figure 4.3C), CCCon (Figure 4.5B), and HRV (Figure 4.6C) among 
baseline, first hour, and last hour, repeated measures ANOVA with post hoc Pair-Sample T-test 
(for normally distributed data) or Friedman Test with Wilcoxon post hoc comparisons (for non-
normally distributed data) were conducted. To analyze the differences of CCCoh between 
SHRSP and WKY (Figure 4.4C), and the differences between feedback and feedforward CCCon 
(Figure 4.5B), independent-sample T-test (for normally distributed data) or Mann-Whitney (for 
non-normally distributed data) test was used. For all the comparisons, p < 0.05 was considered as 
statistically significant. Statistical analyses were performed using the software SPSS (version 
19.0; IBM SPSS Statistics). 
4.3 Results 
4.3.1 Forebrain ischemia claimed 100% mortality in SHRSP rats within 14 hours 
A total of 9 SHRSP and 8 WKY rats underwent BCCAL procedure, which caused 100% 
mortality in SHRSP rats within 14 hours. In contrast, no mortality was observed in WKY control 
rats. The survival length of SHRSP rats ranged from 2.89 hours to 13.92 hours, with a mean 
length of 8.13 hours.  
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4.3.2 SHRSP rats suffering from forebrain ischemia exhibited a marked decrease in RRI 
and increase in cardiac arrhythmias 
The effects of forebrain ischemia on cardiac function was investigated. ECM was first generated 
to facilitate a comprehensive understanding on the dynamic changes of RRI and cardiac 
arrhythmias before and after BCCAL procedure in representative SHRSP and WKY rats (Figure 
4.1A). Figure 4.1B shows the RRI plot for the same pair of SHRSP and WKY rats. As we can 
see in Figure 4.1A and 4.1B, during baseline (-1-0 hour) condition, SHRSP and WKY rats 
displayed similar RRI of about 0.2 seconds [heart rate of 300 beats/minute (bpm)]. After 
BCCAL, RRI for SHRSP rat continued to decline until the sudden collapse of cardiac function at 
7th hour after ischemic stroke, as indicated by the large increase of RRI in the ending phase. In 
sharp contrast, RRI for WKY rat showed mild fluctuations during the entire process. These 
features are conserved for all SHRSP and WKY rats (Figure 4.1C). As shown in the left panel of 
Figure 4.1C, the RRI for SHRSP rats was significantly lower in first hour after ischemia 
(0.17±0.02 second [353 bpm]) than the baseline (0.19±0.01 second [316 bpm]). Moreover, 
SHRSP rats showed a further significant reduction of RRI in the last hour (1.5-0.5 hour before 
sudden death) (0.13±0.01 second [462 bpm]) compared to baseline and first hour after BCCAL. 
However, no significant differences on RRI were found for WKY rats among baseline, first hour 
after BCCAL, and last hour before sudden death (right panel in Figure 4.1C). 
Cardiac arrhythmias before and after forebrain ischemia are summarized in Table 4.1. A 
total of 9 common arrhythmias were identified. Among them, the average hourly occurrence of 
premature ventricular contraction (PVC), sinus pause (SP), junctional rhythm (JR), and second-
degree heart block (2HB) significantly increased after ischemic stroke for both SHRSP and 
WKY rats. However, significant increase in average hourly occurrence for premature atria 
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contraction (PAC), third-degree heart block (3HB), junctional escape beat (JEB), ventricular 
escape beat (VEB), and marked sinus bradycardia (MSB) over baseline was only observed in 
SHRSP rats. In addition, during the last 30 minutes (ending phase) before death, agonal signals 
including 2HB, 3HB, JEB, VEB, and MSB remarkably increased for SHRSP rats, but were not 
identified in any WKY rats. 
 
Figure 4.1 BCCAL results in marked reduction of RRI in SHRSP rats. (A) Electrocardiomatrix (ECM) 
display of ECG signals before and after BCCAL (time 0 sec) for representative rats. (B) RRI before and 
after BCCAL for representative rats. (C) RRI during baseline (-1-0 hour), first hour (0-1 hour), and last 
hour (1.5-0.5 hour before death) for all SHRSP (n=9) and WKY (n=8) rats. Data expressed as mean±SD. 
*Significant differences over baseline, ##significant differences between first and last hour (*/#p < 0.05, 
**/##p < 0.01, ***/###p < 0.001).  
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Table 4.1 Hourly occurrence of cardiac arrhythmias per rat. 
 Time PAC PVC SP JR 2HB 3HB JEB VEB MSB 
SH
R
SP
 
Baseline 
 
1.4±0.4 
 
0.2±0.1 
 
0.7±0.4 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
1.9±1.9 
 
0.0 
 
First Hour 4.4±1.1 
 
17.0±5.9 
** 
0.3±0.2 
 
35.1±26.2 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
Last Hour 1.2±0.6 
 
5.2±2.6 
* 
6.3±3.6 
 
17.4±15.1 
 
5.9±5.9 
 
0.0 
 
11.7±8.9 
 
24.9±19.1 
 
0.2±0.2 
 
Ending 
Phase  
6.2±4.5 
 
6.0±3.0 
 
56.4±48.8 
# 
66.9±48.5 
 
60.7±33.4 
*# 
28.0±15.1 
*#^ 
260.4±69.8 
**##^^ 
106.2±22.5 
**##^ 
255.6±90.1 
*#^ 
Average 5.2±1.4 
** 
13.8±2.7 
** 
14.0±8.4 
** 
42.6±16.5 
* 
3.6±1.4 
* 
1.5±0.7 
* 
25.2±12.1 
** 
23.5±7.2 
* 
23.8±10.1 
* 
W
K
Y
 
Baseline 
 
0.4±0.4 
 
0.3±0.2 
 
0.0 
 
9.0±4.8 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
First Hour 1.6±0.6 
 
3.4±1.1 
* 
2.9±1.3 
 
18.9±8.2 
 
1.4±0.8 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
Last Hour 0.5±0.4 
 
1.5±0.4 
* 
5.8±2.6 
 
118.3±96.2 
 
0.4±0.3 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
Ending 
Phase 
2.0±1.5 
 
0.8±0.4 
 
10.0±5.1 
 
195.3±152.6
* 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
Average 1.2±0.3 
 
2.0±0.4 
* 
6.9±3.1 
* 
131.0±110.5
* 
0.8±0.3 
* 
0.0 
 
0.0 
 
0.0 
 
0.0 
 
PAC: premature atria contraction, PVC: premature ventricular contraction, SP: sinus pause, JR: junctional rhythm, 2HB: second-degree heart 
block, 3HB: third-degree heart block, JEB: junctional escape beat, VEB: ventricular escape beat, MSB: marked sinus bradycardia, baseline: 1 hour 
before BCCAL, first hour: 1st hour after BCCAL, last hour: 1.5-0.5 hour before death, ending phase: 0.5-0 hour before death. Data expressed as 
mean±SDE. *Significant differences over baseline, #significant differences over first hour, ^significant differences over last hour (*/#/^p < 0.05, 
**/##/^^p < 0.01). 
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4.3.3 SHRSP rats exhibited a marked reduction of EEG power following forebrain 
ischemia 
To explore the influence of forebrain ischemia on the electrical activity of the brain, average 
EEG power across all 6 cortical channels before and after BCCAL was analyzed. Figure 4.2A 
shows the EEG power spectrum for all frequencies (0-250 Hz) in representative SHRSP and 
WKY rats. As shown in the figure, EEG power was dramatic reduced for SHRSP rat 
immediately after BCCAL and maintained at low levels until sudden death for all frequency 
bands (upper panel in Figure 4.2A). However, EEG power for WKY rat did not exhibit obvious 
changes over the entire process (lower panel in Figure 4.2A). Figure 4.2B displays the changes 
of EEG power at gamma 1 frequency before and after BCCAL for the same pair of SHRSP and 
WKY rats. In contrast to the nearly stable EEG power in control WKY rat, EEG power for 
SHRSP rat demonstrated a dramatic reduction immediately following forebrain ischemia, which 
then continued to decline until sudden death. Statistical analyses were conducted to compare the 
changes of EEG power among baseline, first hour after BCCAL, and last hour (0.5-1.5 hour 
before sudden death) in all SHRSP and WKY rats. As shown in Figure 4.2C, the significant 
reduction of EEG power in both first hour after BCCAL and last hour before sudden death 
compared to baseline are consistent for all SHRSP rats across all 6 frequencies, which include 
delta, theta, alpha, beta, gamma 1, and gamma 2 (left panel in Figure 4.2C). Additionally, the 
EEG power for last hour was also significantly lower than first hour for delta, theta, alpha, beta, 
and gamma 1 frequencies. In contrast, while showing significant reduction of EEG power in the 
first hour after forebrain ischemic stroke in most frequencies (delta, theta, alpha, beta, and 
gamma 1), WKY rats demonstrated a rebound increase of EEG power in the last hour for all 
frequencies (right panel in Figure 4.2C). EEG power changes for each channel during baseline, 
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first hour, and last hour for all frequencies in SHRSP and WKY rats are shown in Supplement 
Figure 4 in Appendix. 
 
Figure 4.2 BCCAL results in marked reduction of EEG power in SHRSP rats. (A) EEG power spectrum 
before and after BCCAL (at time 0) for all frequencies in representative rats. (B) EEG power before and 
after BCCAL at gamma 1 frequency in representative rats. (C) EEG power during baseline (-1-0 hour), 
first hour (0-1 hour), and last hour (1.5-0.5 hour before death) for all SHRSP (n=9) and WKY (n=8) rats. 
Data expressed as mean±SD. *Significant differences over baseline, ##significant differences between 
first and last hour (*/#p < 0.05, **/##p < 0.01, ***/###p < 0.001). 
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4.3.4 SHRSP rats exhibited a significant increase of CCoh following forebrain ischemia 
To explore the influence of forebrain ischemia on functional connectivity (coherence) of the 
brain, CCoh before and after BCCAL was analyzed. Figure 4.3A shows the CCoh before and 
after BCCAL for all frequencies in representative SHRSP and WKY rats. As shown in the 
figure, there is a marked decrease of CCoh at low frequencies (0-55 Hz) and increase of CCoh 
for high frequencies (65-250 Hz) within 1 hour after BCCAL in SHRSP rat (upper panel in 
Figure 4.3A). After this early phase reduction of low frequency CCoh, CCoh for all frequencies 
demonstrated a dramatic and sustained increase until sudden death. However, for WKY rats, 
while the CCoh at high frequency (65-250 Hz) showed sporadic increases after BCCAL, the 
CCoh for low frequency bands (0-55 Hz) decreased after ischemic stroke (lower panel in Figure 
4.3A). Figure 4.3B displays the CCoh at gamma 1 frequency for the same pair of SHRSP and 
WKY rats. In SHRSP rat, the CCoh for gamma 1 frequency showed a marked reduction within 
the first hour of ischemia, which immediately increased to values that are greater than the 
baseline and persisted for the rest of the recording. In contrast, WKY rat showed a small 
reduction of CCoh after BCCAL and remained at low values for the remaining of the ischemic 
period. Statistical analyses were conducted to compare the CCoh changes among baseline, first 
hour after BCCAL, and last hour (0.5-1.5 hour before sudden death) for both SHRSP and WKY 
rats. As shown in Figure 4.3C, in both SHRSP (left panel) and WKY (right panel) rats, there was 
a dramatic reduction of CCoh in first hour after forebrain ischemic stroke than baseline for 5 
frequencies (delta to gamma 1). In last hour, however, CCoh increased to a level that was 
significantly greater than baseline for SHRSP rats (delta to gamma 1), whereas in WKY rats, 
CCoh in last hour was recovered to a level that is higher than first hour but lower than baseline 
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level. CCoh between each of the 6 cortical channels during baseline, first hour, and last hour for 
all frequencies was shown in Supplement Figure 5 in Appendix. 
 
Figure 4.3 BCCAL results in marked increase of CCoh in SHRSP rats. (A) CCoh before and after 
BCCAL (at time 0) for all frequencies in representative SHRSP and WKY rats. (B) CCoh before and after 
BCCAL for gamma 1 frequency in representative SHRSP and WKY rats. (C) CCoh during baseline (-1-0 
hour), first hour (0-1 hour), and last hour (0.5-1.5 hour before death) all SHRSP (n=9) and WKY (n=8) 
rats. Data expressed as mean±SD. *Significant differences over baseline, ##significant differences 
between first and last hour (*/#p < 0.05, **/##p < 0.01, ***/###p < 0.001). 
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4.3.5 Intermittent surge of functional connectivity between the heart and the brain in 
SHRSP rats following forebrain ischemia 
To investigate the impact of forebrain ischemia on the electrical signal synchronization between 
the brain and the heart, CCCoh before and after BCCAL was calculated. Figure 4.4A shows the 
CCCoh for all frequencies in representative SHRSP and WKY rats. Intermittent surge of CCCoh 
was observed for SHRSP rats after BCCAL (upper panel in Figure 4.4A). However, the CCCoh 
for WKY rats was nearly undetectable in both baseline and after BCCAL procedure (lower panel 
in Figure 4.4A). Figure 4.4B displays the CCCoh at gamma 1 frequency for the same pair of 
SHRSP and WKY rats. In contrast to WKY rat, which demonstrated no obvious changes in 
CCCoh before and after BCCAL, SHRSP rat showed a dramatic surge of CCCoh at gamma 1 
frequency within the first hour of ischemic injury, and a continued and intermittent surge of 
CCCoh throughout the remainder of the recorded period. Statistical analyses were conducted to 
compare the changes on the amplitude of CCCoh and the duration of high CCCoh epochs after 
BCCAL between SHRPS and WKY rats (Figure 4.4C). As shown in figure, a large increase in 
the amplitude of CCCoh after BCCAL over baseline (0.50-1.21-fold increase) was identified for 
SHRSP rats for all frequencies, but was not observed for WKY rats, as indicated by the 0.01-
0.11-fold change of CCCoh amplitude before and after BCCAL among all frequencies (left panel 
in Figure 4.4C). Statistical analysis suggests that the increase of CCCoh amplitude after BCCAL 
was significantly higher in SHRSP than WKY rats. Right panel shows the percentage of signal 
duration with CCCoh amplitude 2 times higher than baseline level over the total duration of the 
signal in all SHRSP and WKY rats. While 13-32% of signals after BCCAL had CCCoh that is 2 
times higher than baseline in SHRSP rats, the CCCoh for WKY maintain at low level after 
BCCAL, with less than 5% of the signals that has CCCoh that is 2 times higher than baseline. 
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Statistical analysis suggests that the percentage of CCCoh epochs that are 2 times larger than 
baseline after BCCAL was significantly larger in SHRSP than WKY rats (right panel in Figure 
4.4C). CCCoh between each of the 6 cortical channels and the heart during baseline, first hour, 
and last hour for all frequencies was shown in Supplement Figure 6 in Appendix. 
 
Figure 4.4 BCCAL results in intermittent surge of CCCoh in SHRSP rats. (A) CCCoh before and after 
BCCAL (at time 0) for all frequencies in representative SHRSP and WKY rats. (B) CCCoh before and 
after BCCAL at gamma 1 frequency in representative rats. (C) Percent changes on the amplitude of 
CCCoh over baseline between all SHRSP (n=9) and WKY (n=8) rats (left panel), percent of signal 
duration with 2 times higher than baseline CCCoh between all SHRSP (n=9) and WKY (n=8) rats (right 
panel). Data expressed as mean±SD. *Significant differences between SHRSP and WKY rats (*p < 0.05, 
**p < 0.01, ***p < 0.001). 
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4.3.6 Intermittent surge of directional connectivity between the heart and the brain in 
SHRSP rats following forebrain ischemia  
To examine the impact of forebrain ischemia on the directional communication between the 
brain and the heart, CCCon before and after forebrain ischemia was analyzed. Figure 4.5A shows 
the feedback (from the brain to the heart or efferent) and feedforward (from the heart to brain or 
afferent) CCCon in a sample epoch that has high CCCoh (corresponding to the shaded region in 
Figure 4.4A) within the first hour after BCCAL in representative SHRSP rat. As shown in the 
figure, a marked surge of connectivity in both theta and gamma 1 frequencies was detected in 
feedforward as well as feedback directions when CCCoh was elevated. However, when the 
CCCoh was low, the heart-brain connectivity was low in both directions for both theta and 
gamma 1 frequencies. Statistical analyses were conducted to compare the changes of 
feedforward and feedback CCCoh for all frequencies among epochs selected from baseline, first 
hour (0-1 hour or first few hours after BCCAL), and last hour (0-0.5 hour before sudden death) 
(Figure 4.5B). As shown in the figure, the significant increase of CCCon after forebrain ischemia 
over baseline values was found in all SHRSP rats, both immediately following ischemia (first 
hour) or during near-death stage (last hour), for all tested frequencies. Additional increase at the 
late stage of ischemia (last hour) over the early stage of ischemia (first hour) was observed for 
delta (feedback), theta (both feedback and feedforward), alpha (both feedback and feedforward), 
and beta (feedforward) frequencies. Directional asymmetry was also detected for theta and beta 
frequencies at the early stage of ischemia, with feedback connectivity dominated over 
feedforward connectivity. CCCon between each of the 6 cortical channels and the heart during 
baseline, first hour, and last hour at all frequencies was shown in Supplement Figure 7 in 
Appendix. 
110 
 
 
Figure 4.5 BCCAL results in increase of CCCon in SHRSP rats. (A) CCCon at theta and gamma 1 
frequencies for one representative epoch that shows high CCCoh. (B) CCCon for selected epochs during 
baseline (-1-0 hour), first hour (0-1 hour or first few hours after BCCAL), and last hour (0-1 hour before 
sudden death). Data expressed as mean±SD. *Significant differences over baseline, #significant 
differences between first and last hour, ^significant differences between feedforward and feedback 
CCCon (*/#/^p < 0.05, **/##/^^p < 0.01, ***/###/^^^p < 0.001). 
4.3.7 SHRSP rats displayed a marked reduction of HRV following forebrain ischemia 
To understand the impact of forebrain ischemia on autonomic regulation of cardiac function 
during ischemic stroke-induced sudden cardiac arrest, HRV analysis was conducted for all the 
rats. The HRV before and after BCCAL in representative SHRSP and WKY rats was shown in 
Figure 4.6A. In SHRSP rat, HRV exhibited reduction at both frequency domain and time 
domain, showing precipitous decline especially at its last hour (upper panel in Figure 4.6A). In 
contrast, WKY rat showed an early reduction of HRV in first and second hour following BCCAL 
procedure, which was then recovered to normal levels in the following hours (lower panel in 
Figure 4.6A). These changes of HRV are conserved in all SHRSP and WKY rats. As shown in 
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Figure 4.6B, in SHRSP rats, both low frequency (LF, 0.25-0.8 Hz) and high frequency (HF, 0.8-
3 Hz) components as well as the ratio of low and high frequency (LF/HF) displayed a reduction 
in first hour after BCCAL and last hour (0.5-1.5 hour before sudden death) than baseline 
condition (left panel in Figure 4.6B). Remarkably, the LF, HF, and LF/HF at last hour are 
significant lower compared to both baseline and first hour. In contrast, WKY rats showed an 
initial decline of LF and LF/HF in first hour after BCCAL, which was followed by a recovery of 
LF, HF, and LF/HF in last hour before sudden death. Different from SHRSP rats, these changes 
of HRV in WKY rats are not significant (right panel in Figure 4.6B).  
 
Figure 4.6 BCCAL results in marked reduction of HRV for SHRSP rats. (A) HRV before and after 
BCCAL (at time 0) for representative SHRSP and WKY rats. z axis represents power spectral density 
(PSD). Warmer color represents stronger PSD. (B) PSD of low frequency (LF), high frequency (HF), and 
LF/HF during baseline (-1-0 hour), first hour (0-1 hour), and last hour (0.5-1.5 hour before death) for all 
SHRSP (n=9) and WKY (n=8) rats. Data expressed as mean±SD. *Significant differences over baseline, 
#significant differences between first and last hour (*p < 0.05, **p < 0.01, ***p < 0.001).  
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4.4 Discussion  
This is the first study to examine the dynamic changes of the brain, the heart, and the functional 
interactions between the brain and the heart in forebrain ischemic stroke-induced sudden cardiac 
arrest rat models. Our data demonstrated that there is a dramatic decline of cardiac functionality 
(increase of RRI and cardiac arrhythmias), disruption of the autonomic nervous system (decrease 
of HRV), and reduction of cortical electrical activity (EEG power) during forebrain ischemic 
cardiac arrest. Importantly, we identified a global increase of functional synchronization within 
the brain (CCoh), as well as a marked and intermittent surge of brain-heart coupling, indicated 
by high level of CCCoh and CCCon, from the onset of ischemia until death in rats that suffered 
from sudden cardiac arrest. These results suggest that abnormal brain-heart connection may be 
the mechanism for forebrain ischemic stroke-induced sudden cardiac arrest and the surge of 
CCCoh may be used as a biomarker to predict the risk of sudden death.  
4.4.1 Animal model for sudden cardiac arrest 
Unlike our previous studies [Borjigin et al., 2013; Li et al., 2015a; Tian et al., 2018] where rats 
experienced global ischemia (asphyxia) that affects the brain and the heart simultaneously, in the 
current model, we investigated brain-heart connection in sudden cardiac arrest induced by 
forebrain ischemic stroke. Comparatively speaking, forebrain ischemia model is scientifically 
more impactful than asphyxia model because it tests the direct influence of cortical ischemia on 
the function of the brain and the heart. In contrast, in asphyxia models, the cortex, brainstem, 
spinal cord, and the heart are globally affected by the experimental insult, making it difficult to 
test the role of the brain during the dying process. BCCAL in SHRSP rats is a well-established 
model for forebrain ischemia [Katayama et al., 1984; Lobanava et al., 2008]. One previous study 
showed that occlusion of the bilateral carotid artery caused the death of SHRSP rats within 6 
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hours, whereas the control WKY rats died within 8 hours after the occlusion [Kakihana and 
Nagaoka, 1983]. In our experiment, BCCAL successfully induced 100% death for SHRSP rats 
within 14 hours. However, no mortality was observed in WKY rats. The high mortality in 
previous study compared to our study may due to the genetic variations for outbred animals, as 
well as the high salt Japanese diet (4% sodium chloride in Japanese diet vs. 0.4% sodium 
chloride in standard chow), which accelerates the development of hypertension in SHRSP rats 
[Matsuo and Nagaoka, 1981; Stier et al., 1988; Schmidlin et al., 2005]. Nevertheless, large 
similarities in mitochondria abnormalities and cerebral blood vessel deficits during the 
development of stroke have been identified between SHRSP rats and humans, making BCCAL 
in SHRSP rats one of the most relevant model for studying sudden cardiac arrest induced by 
forebrain cerebral ischemia [Lobanava et al., 2008]. 
4.4.2 Deterioration of cardiac function and autonomic nervous system functionality during 
forebrain ischemic stroke-induced sudden cardiac arrest 
Cardiac arrhythmias and ECG abnormalities are commonly observed after acute cerebrovascular 
events, such as ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage 
[Goldstein, 1979; Daniele et al., 2002]. In stroke patients, cardiac arrhythmias, especially the 
malignant ventricular arrhythmias triggered by the impairment of the central autonomic nervous 
system structures and catecholamine storm, are highly prevalent [Myers et al., 1982; Mäkikallio 
et al., 2004]. It is also known that ventricular tachycardia (VT), ventricular fibrillation (VF), and 
asystole, are often the fatal cardiac arrhythmias right before sudden death [Bayes de Luna et al., 
1989]. However, none of previous studies have characterized the number and types of cardiac 
arrhythmias with the progression of cardiac arrest in forebrain ischemic stroke-induced sudden 
cardiac arrest rat model, except for one earlier study which reported the disturbance of cardiac 
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rhythm and increase in the number of PVC in SHRSP rats after BCCAL [Kakihana et al., 1983]. 
In our study, we showed that common arrhythmias including PVC, PAC, SP, JR and 2HB 
significantly increased after the surgery in both SHRSP and WKY rats, although on average 
more arrhythmias were found in SHRSP rats than WKY rats. The occurrences of those 
arrhythmias are sporadic and irregular in both strains. In contrast, in last 30 minutes before death, 
there is a sudden increase of cardiac arrhythmias only in SHRSP rats, suggesting that the 
disruption of cardiac function is essentially very sudden, which further proves the validity of 
current model for investigating the mechanism of sudden cardiac death. Interestingly, different 
from asphyxic cardiac arrest model, in which 3HB, JEB, VEB, VT, and VF are the last cardiac 
arrhythmias before sudden death [Tian et al., 2018], in forebrain ischemic cardiac arrest model, 
VT and VF are not identified. Instead a significant increase of MSB was observed in SHRPS rats 
right before sudden death.  
HRV has been widely used for studying the autonomous nervous system control of 
cardiovascular function [Task force et al., 1996]. Reduced HRV has been associated with the risk 
of myocardial infarction [Lombardi et al., 1987; Buchanan et al., 1993], congestive heart failure 
[Saul et al., 1988], and sudden cardiac death [Politano et al., 2008; Wu et al., 2014]. Parallel with 
previous findings, our study demonstrated a significant reduction of LF, HF, and the ratio of 
LF/HF in SHRSP rats that suffered from sudden cardiac death, whereas the HRV in control 
WKY rats did not display significant changes during the entire process. These results indicate 
that forebrain ischemia leads to reduced level of activity for both the sympathetic and 
parasympathetic nervous system, with more severe suppression to the parasympathetic nervous 
system at near-death. The reduction of the autonomic nervous system functionality may be the 
cause for the dramatic increase of MSB during the ending phase of forebrain ischemic sudden 
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death. In contrast, in asphyxic cardiac arrest, the sympathetic nervous system is over-activated 
since the blockade of sympathetic nervous system via either spinal cord transection or adrenergic 
blockers prolongs the electrical activities of both the brain and the heart [Li et al., 2015a; Tian et 
al., 2018]. The cardiac arrhythmias observed in the ending phase are therefore VT and VF. The 
differences of cardiac arrhythmias and autonomic nervous system functionality indicate that 
global ischemia (asphyxia) and forebrain ischemia induced very different autonomic responses 
and cardiac pathological consequences. 
4.4.3 Decrease of cortical power and increase of cortical coherence during forebrain 
ischemic stroke-induced sudden cardiac arrest 
Consistent with previous studies in mice and rats that suffered from cardiac arrest induced by 
injection of potassium chloride [Borjigin et al., 2013; Weitzel et al., 2016], severe and sustained 
reduction in EEG power was identified in SHRSP rats after forebrain ischemic stroke. As 
expected, an initial decline and a subsequent recovery of EEG power was found in WKY rats 
that survived. Another study investigating the EEG power changes in spontaneously 
hypertensive rats (SHR has elevated blood pressure but rarely shows signs of stroke [Okamoto 
and Aoki, 1963]) and WKY rats after forebrain ischemia demonstrated that 20-minute BCCAL 
plus hypotension produces dramatic increase in delta power and decrease in theta, beta, and 
alpha activities [Mariucci et al., 2003], which is comparable to what we found in SHRSP and 
WKY rats that EEG power for all frequencies significantly decreased after permanent BCCAL. 
In addition, similar to what we found for SHRSP and WKY rats, EEG activity also recovered to 
normal values more quickly in WKY rats than in SHR rats, in which alpha and beta power did 
not recover even at 6 days of reperfusion [Mariucci et al., 2003]. The irreversible influence of 
forebrain ischemic stroke on brain electrical activity in SHRSP and SHR rats but not WKY rats 
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may due to the abnormal cerebral vascular structure, hypertension, and altered hemodynamics of 
spontaneous hypertensive rats, which makes SHRSP and SHR rats more susceptible to ischemic 
insult than normotensive rats [Ogata et al., 1976; Fujishima et al., 1980; Kakihana et al., 1983; 
Coyle, 1986; Brint et al., 1988; Duverger and MacKenzie, 1988; Lobanova et al., 2008].  
Immediately after BCCAL, the functional synchronization (CCoh) between different 
cortical regions in SHRSP rats significantly decreased. This is possibly due to the dysfunction or 
death of a considerable number of cortical neurons that severely impairs the information 
transmission in cortical connection after forebrain ischemia. This result was consistent with 
findings from previous studies in Wistar rats undergoing BCCAL and in patients with acute 
thalamic ischemic stroke, both of which showed a decrease of cortical coherence or functional 
connectivity within the brain after ischemia [Kozhechkin et al., 2009; Liu et al., 2016]. 
Interestingly, within 1 hour after BCCAL, CCoh in SHRSP rats recovered to a level that was 
even greater than baseline, indicating that the brain is internally super-activated at near-death. 
The neurophysiological mechanisms underlying the marked surge of the functional coupling 
within the brain after ischemia is still unknown. Nevertheless, the large increase of brain 
functional synchronization after forebrain ischemic stroke until sudden death is consistent with 
our earlier findings in both potassium chloride injection- and asphyxia-induced cardiac arrest 
models, in which a dramatic increase of both functional and effective connectivity was identified 
within the brain before sudden death [Borjigin et al., 2013; Li et al., 2015a]. The identification of 
dramatic surge of CCoh exclusively in rats that suffered from sudden cardiac arrest provides 
further evidence to support our central hypothesis that the brain may play an active role in 
mediating the dying process. 
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4.4.4 Increase of brain-heart connection during forebrain ischemic stroke-induced sudden 
cardiac arrest 
Despite growing evidence suggesting that abnormal interaction between the brain and the heart is 
the major cause of sudden death, the dynamical changes of brain-heart connection have not been 
characterized in any neurogenic sudden death models before due to the lack of effective study 
tools [Samuels, 2007; Dorrance and Fink, 2015; Gonzales-Portillo et al., 2016]. In previous 
study, we developed novel analysis methodologies, CCCoh and CCCon, to investigate the 
synchronization and bi-directional signal communication between the brain and the heart in 
asphyxic cardiac arrest models [Li et al., 2015a]. Consistent with our findings from that study [Li 
et al., 2015a], a surge of coherence (CCCoh) was identified between the brain and the heart in 
SHRSP rats that died after forebrain ischemia and the surge was absent in WKY rats as well as in 
SHRSP rats survived a milder form of stroke. In addition, strong bi-directional information 
transfer between the brain and the heart (CCCon) was also found in SHRSP rats whenever there 
was increased brain-heart coupling. However, there are two differences of CCCoh and CCCon 
between asphyxia- and forebrain ischemic stroke-induced sudden cardiac arrest models: 1) high 
level of CCCoh and CCCon was detected for all frequencies (0-250Hz) in forebrain ischemic 
cardiac arrest model, whereas in asphyxic cardiac arrest model, CCCoh was clustered at low 
frequency ranges (0-55 Hz); 2) The CCCoh in SHRSP rats after forebrain ischemic stroke is 
intermittent and unevenly distributed, however, in asphyxic cardiac arrest model, CCCoh 
displays homogeneous and continuous pattern. As the detailed biophysical mechanism 
underlying CCCoh and CCCon remain to be discovered, it still unknown what are the causes of 
the distinct frequency and temporal patterns in two different models. Results from this study and 
our previous study suggest that there are strong functional and directional connectivity between 
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the brain and the heart in the dying process, and the brain and the heart displays different modes 
of interaction during global (asphyxia) and forebrain ischemic sudden cardiac arrest. 
4.4.5 Conclusion 
In conclusion, this study demonstrated that during forebrain ischemic stroke-induced sudden 
cardiac arrest, elevated brain-heart electrical signal coupling and communication are highly 
associated with the increase of cardiac arrhythmias, disruption of the autonomic nervous system, 
and the risk of sudden death, and may be used a potential biomarker to predict sudden death. 
This study could improve our understanding on the mechanism of how the brain and the heart 
interact during forebrain ischemic sudden cardiac arrest. Based on results from this study and 
previous studies, we hypothesis that under normal condition, the brain and the heart 
communicate indirectly via the autonomic nervous system to ensure the homeostasis of 
fundamental physiological systems. However, when this homeostasis is disrupted by the external 
perturbations, either asphyxia [Li et al., 2015a; Tian et al., 2018], neurological diseases (current 
study), or cardiac abnormalities (Chapter 3), the regulation from the autonomic nervous system 
fails. The brain starts intense interaction with the heart via other unknown mechanisms, which 
are detected and quantified by the dramatic surge of CCCoh and CCCon. Till now, it is unknown 
what mediates the strong brain-heart interaction during sudden death. We hypothesize that it may 
be mediated by the vascular system as CCCoh is still detectable after spinal transection, but this 
needs to be tested in further studies. Our results may also provide important information for 
predicting and preventing sudden death after ischemic stroke. Since the bi-directional electrical 
signal coupling (CCCoh) and communication (CCCon) between the brain and the heart are only 
identified in dying animals, they could be used as potential biomarkers to predict the risk of 
sudden death. The diminishment of CCCoh and CCCon may also be used as parameters to 
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evaluate the effectiveness of drugs in preventing sudden death. In addition, this study further 
corroborates the possibility of functional investigation on brain and heart connection using 
advance signal processing techniques. Areas of future interests would include testing whether 
CCCoh is also detectable in other types of neurological injury-induced sudden death animal 
model or human patients.  
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Chapter 5 Conclusions 
5.1 Significance of thesis project 
Through this thesis project, we established a novel mechanism for sudden cardiac arrest. 
Different from the conventional view that the brain is hypoactive during sudden cardiac arrest, 
our data strongly suggest that the brain plays an active role in mediating the deterioration of 
cardiac function at near-death, and that corticocardiac coupling may be a common mechanism 
underlying sudden cardiac death induced by different causes, which include asphyxia that affects 
both the heart and the brain, cardiac abnormalities, and neurological diseases.  
This thesis project is significant scientifically, clinically, and technically because: 1) It 
provides new insights into the neurophysiological mechanisms underlying sudden cardiac arrest. 
The bidirectional corticocardiac coupling has never been described in any sudden cardiac arrest 
animal models or human patients before. This is the first study demonstrating the existence of 
significant level of functional coupling and directional communication between the brain and the 
heart at near-death stage in different models. Interestingly, the functional and directional 
connectivity displays hemispheric asymmetry, frequency specificities, and different temporal 
dynamics in different models, suggesting the existence of diverse modes of communication 
between the brain and the heart in sudden death triggered by different factors or in different 
species. 2) Investigating the mechanism of how the brain and the heart interact during sudden 
cardiac arrest could contribute to the development of novel therapeutic approaches to predict and 
prevent sudden death. This project established that corticocardiac coupling may be used as a new 
non-invasive method to assess the risk for sudden death since corticocardiac coupling is 
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exclusively identified in rats or human undergoing sudden death. This study also validated the 
effectiveness of pharmacological interventions for prolonging the survival after cardiac arrest in 
experimental animal models. 3) This study successfully applied advanced signal processing 
technique to study the dynamic changes of brain-heart connection in rats and human patients 
suffering from sudden cardiac arrest. Although signal processing techniques have been widely 
used to explore the features associated with brain signals, no published studies have applied it to 
the investigation of the functional coupling and directional communication between cortical and 
cardiac signals in any human or animal models. Our study is among the first to use advanced 
analytical techniques to functionally characterize the dynamic interactions of the brain and the 
heart, and is expected to provide a new framework for functional investigation of both 
neurogenic as well as cardiogenic sudden death and many other diseases caused by abnormal 
brain-heart connection. Successful validation of this powerful new technology in probing the 
dynamics of corticocardiac network could also contribute to the understanding of the 
neurophysiological connections between the brain and other peripheral organs in normal and 
disease conditions.  
5.2 Future directions 
The understanding of the functional connection between the cerebral cortex and the heart is still 
in its early stage. Based on current finding, we think there are two future directions worth 
pursuing: 1) Further investigation on the biophysical nature of corticocardiac coupling. Although 
we identified consistent surge of corticocardiac coupling in different sudden cardiac arrest 
models, the neurophysiological pathways by which the heart and the brain communicate or the 
biophysical nature of corticocardiac coupling is still unknown. Understanding the biophysical 
nature of corticocardiac coupling and the way that the brain communicates with the heart will 
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provide important information for the development of novel strategies for predicting and 
preventing sudden death. We hypothesize that the corticocardiac coupling may be mediated by 
the vascular system though gap-junctions because corticocardiac coupling was still detectable in 
rats with spinal nerve transection, but this hypothesis needs to be tested in future studies. 2) Test 
the brain-heart connection in focal ischemic stroke model. Focal ischemic stroke is one of the 
major causes of mortality and morbidity around the world and is responsible for the leading 
health care costs of all diseases. Focal stroke can trigger cardiac autonomic imbalance, which 
may put susceptible patients at increased risk of cardiac arrhythmias and sudden death. In the 
current thesis project, we established the role of the brain in sudden cardiac death. To further test 
specific cortical regions that are important for cortical control of cardiac function, we plan to 
investigate the brain-heart connection in focal ischemic stroke model with 10 EEG electrodes 
implanted on the cerebral cortex. Questions of interest include how the injured cortical region 
interacts with the healthy region of the brain, and how different cortical region communicate 
with the heart during the development of focal ischemic stroke. This study is expected to 
contribute to our understanding on the temporal dynamics of cortical activity and key brain 
regions that may be involved in the regulation of cardiac function during focal ischemic stroke.
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Appendix 
 
Supplement Figure 1 ECG signals with representative cardiac arrhythmias in each stage of asphyxic 
cardiac arrest for 4 groups of rats. (A) Saline group. A1: 1 premature atria contraction (green arrow) and 1 
first-degree heart block (red arrow); A3: 3 junctional escape beat (green arrow) and 2 ventricular escape 
beat (red arrow) in a background of third-degree heart block; A4a: ventricular tachycardia; A4b: 
ventricular fibrillation. (B) Phentolamine group. A2: second-degree heart block type II; A3: 1 junctional 
escape beat (green arrow) and 3 ventricular escape beat (red arrow) in a background of third-degree heart 
block; A4a: ventricular tachycardia; A4b: ventricular fibrillation. (C) Atenolol group. A1: 1 premature 
junctional contraction (red arrow) in a background of junctional rhythm; A2: 1 premature ventricular 
contraction (red arrow); A3a: junctional escape beat in a background of third-degree heart block; A3b: 
ventricular escape beat in a background of third-degree heart block. (D) Phentolamine plus atenolol 
group. A1: 1 premature ventricular contraction (green arrow) and 1 ventricular couplet (red arrow) in a 
background of peaked T waves; A2: 3 second-degree heart block type II (red arrow); A3a: junctional 
escape beat in a background of third-degree heart block; A3b: ventricular escape beat in a background of 
third-degree heart block. 
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Supplement Figure 2 ECM and EEM for 19 EEG channels (arranged according to their locations on the 
skull) for a 40-second long epoch during S4. 
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Supplement Figure 3 ECM and EEM for 19 EEG channels (arranged according to their locations on the 
skull) for a 40-second long epoch during S6.  
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Supplement Figure 4 EEG power for each of the 6 cortical channels during baseline, first hour, and last 
hour in all SHRSP (n=9). (A) and WKY (n=8) (B) rats for 6 frequencies. LF: left frontal, RF: right 
frontal, LP: left parietal, RP: right parietal, LO: left occipital, RO: right occipital. Data expressed as 
mean±SD. *Significant differences between two channels (*p < 0.05, **p < 0.01, ***p < 0.001). 
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Supplement Figure 5 Cortical coherence (CCoh) between every 2 of the 6 cortical channels during 
baseline, first hour, and last hour in all SHRSP (n=9). (A) and WKY (n=8) (B) rats for 6 frequencies. LF: 
left frontal, RF: right frontal, LP: left parietal, RP: right parietal, LO: left occipital, RO: right occipital.  
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Supplement Figure 6 CCCoh for each of the 6 cortical channels during baseline, first hour, and last hour 
for in all SHRSP rats (n=9) at 6 frequencies. LF: left frontal, RF: right frontal, LP: left parietal, RP: right 
parietal, LO: left occipital, RO: right occipital. Data expressed as mean±SD. *Significant differences 
between two channels (*p < 0.05, **p < 0.01, ***p < 0.001).  
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Supplement Figure 7 Feedback (A) and feedforward (B) CCCon for each of the cortical channels during 
baseline, first hour, and last hour in all SHRSP rats (n=9) for 6 frequencies. LF: left frontal, RF: right 
frontal, LP: left parietal, RP: right parietal, LO: left occipital, RO: right occipital. Data expressed as 
mean±SD. *Significant differences between two channels (*p < 0.05, **p < 0.01, ***p < 0.001).  
 
